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ABSTRACT

The development of bioinformatics methods for human genetic studies utilizes the
vast amount of data to generate new valuable information. Machine learning and statistical
coupling analysis can be used in the study of human diseases. These diseases include
intellectual disabilities (ID), prevalent in 1-3% of the population and caused primarily by
genetics. Although many cases of ID are caused by mutations in protein-coding genes, the
possible involvement of long non-coding RNAs (lncRNAs) in ID due to their role in gene
expression regulation, has been explored. In this study, we used machine learning to
develop a new expression-based model trained using ID genes encoded with the developing
brain transcriptome. The model was fine-tuned using the class-balancing approach of
synthetic over-sampling of the minority class, resulting in improved performance. We used
the model to predict candidate ID-associated lncRNAs. Our model identified several
candidates that overlapped with previously reported ID-associated lncRNAs, enriched with
neurodevelopmental functions, and highly expressed in brain tissues. Machine learning
was also used to predict protein stability changes caused by missense mutations, which can
lead to disease conditions including ID. We tested Random Forests, Support Vector
Machines (SVM) and Naïve Bayes to find the best-performing algorithm to develop a
multi-class classifier. We developed an SVM model using relevant physico-chemical
features after feature selection. Our work identified new features for predicting the effect
of amino acid substitutions on protein stability and a well-performing multi-class classifier
solely based on sequence information. Statistical approaches were used to analyze the
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association between mutations and phenotypes. In this study, we used statistical coupling
analysis (SCA) to cluster disease-causing mutations and ID phenotypes. Using SCA we
identified groups of co-evolving residues, known as protein sectors, in ID protein families.
Within each distinct sector, mutations associated with different phenotypic manifestations
associated with a syndromic ID were identified. Our results suggest that protein sector
analysis can be used to associate mutations with phenotypic manifestations in human
diseases. The bioinformatic methods developed in this dissertation can be used in human
genetic research to understand the role of new genes and proteins in human disease.

iii

DEDICATION

I dedicate this thesis to my parents, siblings, close family and dear friends Shenise,
Jake, Aaron and my partner Sarah. The love and support given by them made this possible.

iv

ACKNOWLEDGMENTS

I wish to thank my advisor Dr. Wang for his support and guidance throughout my
research. His knowledge and teachings have provided me with the foundations to grow into
a better bioinformatics researcher every day. I appreciate Dr. Cao for his support and
providing the opportunity for exciting research collaborations. Also, Dr. Schwartz, for the
opportunity to be part of the Greenwood Genetic Center and for providing valuable insight
into human genetics. Dr. Sehorn, for his research and career advice. I want to extend my
appreciation to Dr. Marcotte and Dr. Frugoli for their support and assistance. A special
acknowledgment to my group members Brian Gudenas, Jun Wang and Shuzhen Kuang.
Special recognition to the assistance provided by Austin Gorman, Eda Ozyesilpinar, and
Kalee Lineberger at the Writing Center, and Priscilla Harrison from the Office of Access
and Equity. Finally, a warm thank you to the staff and faculty of Clemson University that
supported and assisted me in obtaining my PhD.

v

TABLE OF CONTENTS
Page
TITLE PAGE .................................................................................................................... i
ABSTRACT..................................................................................................................... ii
DEDICATION ................................................................................................................ iv
ACKNOWLEDGMENTS ............................................................................................... v
LIST OF TABLES ........................................................................................................viii
LIST OF FIGURES ........................................................................................................Ix
CHAPTER
I.

LITERATURE REVIEW .............................................................................. 1
Introduction to Bioinformatics................................................................. 1
Overview of Machine Learning ............................................................... 5
Intellectual Disabilities and Long Non-coding RNAs ........................... 14
References .............................................................................................. 26

II.

EXPRESSION-BASED PREDICTION OF CANDIDATE LONG NONCODING RNAS ASSOCIATED WITH INTELLECTUAL DISABILITY
................................................................................................................ 39
Abstract .................................................................................................. 39
Background ............................................................................................ 40
Methods.................................................................................................. 42
Results and Discussion .......................................................................... 45
Conclusion ............................................................................................. 49
Tables ..................................................................................................... 50
Figures.................................................................................................... 55
References .............................................................................................. 58

III.

THREE-STATE PROTEIN STABILITY PREDICTION FROM SEQUENCEBASED FEATURES ............................................................................. 64
Abstract .................................................................................................. 64

vi

Table of Contents (Continued)
Page
Introduction ............................................................................................ 65
Methods.................................................................................................. 66
Results .................................................................................................... 69
Conclusion ............................................................................................. 71
Tables ..................................................................................................... 72
References .............................................................................................. 75
IV.

PROTEIN SECTOR ANALYSIS FOR THE CLUSTERING OF DISEASEASSOCIATED MUTATIONS .............................................................. 78
Abstract .................................................................................................. 78
Background ............................................................................................ 79
Methods.................................................................................................. 81
Results and Discussion .......................................................................... 84
Conclusion ............................................................................................. 89
Figures.................................................................................................... 90
Table ...................................................................................................... 93
References .............................................................................................. 95

V.

CONCLUSIONS ..........................................................................................99

APPENDIX

.............................................................................................................. 101
A: MUTUAL INFORMATION TO IDENTIFY CORRELATED SITES
IN URACIL DNA GLYCOSYLASE SUPERFAMILY ..................... 102

vii

LIST OF TABLES
Table

Page

1.1

Growth and change of major sub-fields in biological research
focused on a publication-based search of the Web of Science (WoS)
spanning from 1991-2010 ................................................................................. 4

2.1

Performance of the SVM, Naïve Bayes, and Random Forest models
based on tenfold cross-validation................................................................. 50

2.2

Performance of the SVM models after feature selection and
synthetic oversampling of the minority class (SMOTE) ............................. 51

2.3

List of selected candidate lncRNAs from this study.................................... 52

3.1

Performance of the SVM and RF models based on
tenfold cross-validation................................................................................ 72

3.2

Performance of the SVM models after feature selection based on
tenfold cross validation ................................................................................ 73

3.3

Predictive performance of the SVM models on an
independent test dataset .............................................................................. 74

4.1

List of the residues associated with diseases in spermine synthase
and Rab GDP dissociation inhibitor ............................................................ 93

viii

LIST OF FIGURES
Figure

Page

1.1

Illustration of how SMOTE creates new synthetic instances ...................... 14

1.2

Schematic overview of lncRNA regulatory mechanisms ............................ 23

2.1

ROC curves of the SVM models constructed using the full and
reduced feature sets in combination with the SMOTE method
to overcome class imbalance ....................................................................... 55

2.2

Co-enrichment of lncRNAs and ID genes in brain
co-expression modules ................................................................................. 56

2.3

Expression patterns of the ID-associated candidate lncRNAs ..................... 57

4.1

Proposed pipeline for analyzing co-evolving residues from
protein families associated with human diseases ......................................... 90

4.2

Identification of protein sectors in the primary structure
of SMS and GDI1 ........................................................................................ 91

4.3

Representation of protein domains and identified sectors in the
3D structure of spermine synthase (PDB: 3C6K) ........................................ 92

ix

CHAPTER I – LITERATURE REVIEW

1.1 Introduction to Bioinformatics
The term bioinformatics was coined in the 1970s by Paulien Hogewegen and Ben Hesper to define
the use of informatic technologies in the study and understanding of biological processes [1]. This definition
can be further expanded to state that bioinformatics is the science that looks to understand and organize,
via computational approaches, the function, role, and information associated with biological
macromolecules [2,3]. Although seemingly distant at first glance, at a closer look, life can be described as
an information system. The fact that there is terminology such as genetic code, used to refer to the genetic
material and how it is stored, and that this crucial information for survival needs to be encoded, stored, and
eventually transferred, shows the close ties to information systems [1,2,4].
Originally envisioned as an approach for sequence analysis [2,4], bioinformatics evolved into a
more complex field due to the increasing power of computers. Previous reports [5,6] describe that the goal
of bioinformatics is to organize and understand biological data. In its current form, it is understood that
bioinformatics has a broader scope, including the development of methods for data analysis and knowledge
discovery from biological datasets [7]. The wide array of tasks undertaken by a bioinformatician can be
summarized in three main areas:
1.

Data management: This area focuses on accessing, combining, converting, manipulating, storing,

and annotating data. Data management requires routine quality checks, automatization of existing methods,
and summarization of large datasets.
2.

Data processing: This area requires running a variety of tools that include but are not limited to

aligners, variant callers, RNA-Seq quantifiers, transcript analyzers, etc. During the preparation for the
analysis, the bioinformatician must anticipate and prepare for potential pitfalls that could present
themselves, and develop alternative solutions/analyses that fit the data.
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3.

Knowledge discovery: Knowledge discovery has a crucial function in the interpretation of the data.

The data a bioinformatician gathers through data management and processing would remain uninformative
without insightful interpretation. By using biological data and computational methods, knowledge
discovery can extract insightful information from the data, providing new and valuable information.
Bioinformatics has three main aims. The first, which is highly associated with one of the areas, is
organization and management of biological data. This allows the scientific community access to existing
information as well as submit new entries in various repositories such as GenBank [8], Protein Data Bank
[9] or UniProtKB [10]. Data management not only includes the incorporation of new data entries but also
the process of data curation, which refers to the manual validation of the quality of the entries or the datasets
[1–4]. The second aim is to develop tools and resources for the analysis of data that has been stored in the
repositories. This aim is closely related to the second and third areas that are essential in bioinformatics, as
such tools are necessary for data analysis and data interpretation. To accomplish this aim, computational
and biological knowledge and expertise are required [2,3,7]. The third aim is the use of the tools and
methods developed for data analysis and their implementation to extract new information from biological
datasets to further the understanding of biological systems. It is possible to use the methods to understand
biological systems in a single organism view, where the system is seen as an independent entity, or a multiorganism approach where it is possible to uncover shared relationships and interactions amongst different
biological systems [1–3,5–7,11].
Currently, bioinformatics research has grown and evolved to cover the fields of structural biology,
genomics, and evolutionary biology [4–6]. Interestingly, someone working in the field of bioinformatics
must have analytical skills and knowledge in statistics and computer sciences, making it an interdisciplinary
field that requires competency in various areas. The ability of bioinformatics to incorporate knowledge and
methods, initially developed to analyze data from other fields into the biological context, has made it
invaluable in the current research environment.
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Bioinformatics has been enriched by a community that continuously provides support and
advancement of the available methods. This in turn allows the integration of the various methods for
pipeline construction, exemplified by programming languages such as R or Python which provide multiple
packages or libraries with supported and integrated modules that have been developed by community
members. In most cases, these packages or modules have been published in peer-reviewed journals [12–
14]. Published materials tend to be hosted, maintained, and updated by their developers, providing the basis
for reproducibility, provenance, and upgradability of the methods [11,15,16]. In return, a competent
bioinformatician can use the programming language and the supporting packages/modules to develop
methods that can generate novel information from the data.
The importance of this field can be seen in the increasing number of publications related to this
area. The impact of bioinformatics as a research field was shown in a study by [17], where the number of
publications from 1991-2010 for different fields and sub-fields in the Web of Science for the biological
sciences were compared. Subsequently, the number of publications in the different sub-fields were
quantified for the periods encompassing the last five and three years of the study. The results indicate that
the growth of bioinformatics papers per annum appears to follow an exponential pattern, and that the
amount of bioinformatics-related journal articles increased by 65% in the five-year period of the study, only
third behind synthetic biology and systems biology. The data from this study has been adapted and
summarized in Table 1.1.
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Table 1.1 Growth and change of major sub-fields in biological research focused on a publication-based
search of the Web of Science (WoS) spanning from 1991-2010. The table indicates the number of
publications, the growth for each sub-field per year as exponential or linear based on the number of
publications recorded, the changes observed per sub-field as percentages of publications and the
percentage of published papers for the sub-filed in the period of 2006-2010, data from Pautasso (2012)
[17].

Change in
Publications
Sub-field

in WoS
1991-2010

Publication
Growth/Year

Number of
Publications
(%) 19912010

Synthetic
Biology
Systems
Biology*
Bioinformatics
Structural
Biology
Cell Biology
Ecology and
Evolution*
Genetics
Molecular
Biology
Biochemistry

Percentage
of
Publications
2006-2010

8.50E+02

Linear

0.7

94

6.20E+03

Exponential

3.7

84

1.70E+04

Exponential

6.8

65

2.20E+03

Linear

0.6

54

1.10E+04

Exponential

1.2

50

2.40E+04

Exponential

1.6

48

8.50E+04

Linear

-7.2

40

2.20E+04

Linear

-5.3

31

2.50E+04

Exponential

-10.1

31
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In summary, the role of bioinformatics has seen a change from the sequence-analysis oriented field
in the 1970s to a more multi-disciplinary area in the 1990s. However, the major shift in the paradigm
appeared to come around the late 1990s or early 2000s. According to Pop and Salzberg [18] and Mardis et
al. [19] emphatic change can be attributed to the impact that the Human Genome Project had on influx of
data and the need of new methods to analyze it. Bioinformatics has also seen a change from a support role
in research to a more central one. Currently, bioinformatics has become a key component in modern
research, from candidate gene prediction to drug target discovery. In this dissertation, using bioinformatical
approaches, such as supervised machine learning and statistical analysis of multiple sequence alignments
for functional analysis of protein families, new knowledge has been generated for human genetic studies.

1.2 Overview of Machine Learning
In its essence, machine learning refers to the field concerned with the development and application
of computer algorithms that improve with knowledge or experience [20]. The learning process usually
utilizes a set of example data to teach an algorithm in a manner that it will eventually achieve the optimal
performance, or criterion [20,21]. This criterion can be represented as a series of measurements—for
example, the accuracy of a model in a classification problem, or the value of a fitness function in an
optimization problem [21]. Because of their predictive capabilities, machine learning models have become
commonplace in different fields, from research in the sciences and engineering, such as fuel efficiency
prediction in automobiles [22], to the business environment [23,24], with stock price prediction. In the field
of biological sciences and more specifically in genetics and genomics research [21,25], machine learning
has been of great importance to model problems using large datasets, which, due to their size, cannot be
modelled using traditional statistical methods. In studies where machine learning has been used, it has
provided valuable information from these large and complex datasets, such as the function of open reading
frames in yeast using mutant phenotype data, or pathway identification in plants from large transcriptomics
sets [25–28]. Machine learning has also been used to address tasks deemed time-consuming to solve using
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other approaches. By efficiently harnessing the potential of big data [28], machine learning approaches
have been able to generate classifiers that have provided new insight into the possible genetic causes
associated with human diseases such as cancer [29] and autism [30], as well as novel biomarker
development [31] and drug target discovery [32].
The machine learning process consists of transforming data into knowledge. This can be done in
both the construction and validation stages [21,33,34]. The construction part of the process is composed of
a sequential series of steps, starting with dataset pre-processing. In the pre-processing step, the data is
curated, and inconsistencies are identified and resolved [20,21,33,34]. It is during data pre-processing that
normalization strategies such as z-score standardization, or missing data handling techniques, like
imputation, are applied to the dataset [20].The outcome of this step is a high-quality dataset defined as the
training set. Subsequently, dimensionality reduction can be performed. This process includes feature
extraction and feature selection. Feature selection is focused on selecting the subset of important features,
whereas feature extraction creates new features by transforming raw data using methods such as principal
component analysis. This is followed by training a predictive model, where machine learning methods and
frameworks are used to model and analyze the data. The idea of training a model aims to develop a learner
capable of extracting significant information from the data (knowledge discovery) [21,28,33–35]. The built
models need to be validated and evaluated using performance metrics. Further interpretation from domain
experts should be done to provide an additional layer of validation of the significance of the information
extracted from the data, if any, that the model can provide. If inconsistencies are found at any point of
model construction, it is possible to revert to a prior step in order to retrace and troubleshoot. However, if
the model is deemed satisfactory, in terms of performance metrics or validity of biological information, it
can provide new insight into the biological system [20,21,29].
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1.2.1 Supervised Machine Learning
In a simple overview, a supervised machine learning problem can be a classification task that
consists of a dataset that is divided into different classes, each with a known label. The label represents the
relationships between the inputs (data instances) and the outputs (predictions) [33]. Supervised machine
learning evolved from pattern recognition, and aims to identify hidden signals that are commonly shared
within a class [24,36]. The presence of the output or response variable is what marks a clear distinction
between supervised learning and unsupervised learning, where the instances are unlabeled [33,37].
In supervised learning, the algorithm analyzes the inputs in the labelled training set and generates
a function which can predict the class label for each data instance [33,36]. These predictions are based on
supervised learning’s pattern recognition abilities, which identify common or shared signals between data
instances that have the same label [38,39].
It is important to determine the generalization capabilities of a model. This is usually determined
through validation methods, a process designed to evaluate the model’s overall quality using accuracy and
other metrics [21,28], or to detect over-fitting. There are multiple approaches to evaluate the model. These
include a holdout set, where the training data is separated into two splits; one is used for training and the
other for validation [21,40]. Also in cross-validation is 10-fold or 5-fold, where the dataset is split into n=
5 or 10 subsets of the same size, and the training set is n-1, while the remainder is used for validation. The
leave-one-out (LOO) cross-validation is included within the leave-p-out cross-validation, where p instances
are left-out for validation while the rest are used for training. In LOO cross-validation, p = 1, meaning that
for each round of cross-validation, statistics are calculated for the left-out sample and the remaining samples
are used for training [21,40–42].
After model construction and validation, it is a recommended practice to determine the model’s
generalization capabilities and performance with a test set. The test set has to be independent from the
training data, thus remaining “unseen.” Although the test set is independent from the training set, and as it
has never been used for training purposes, both the training and test sets should have a similar probability
distribution for the feature values. Otherwise, results would not be informative, as the differences in training
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and test sets make prediction impossible [35,41]. If the training set would have included the test data, then
the assumption of independence would no longer be valid. Another important aspect of this separation
between training set and test set is that if model performance is high on the training set but significantly
lower on the test set, poor model generalization or over-fitting can be potentially identified [33], as the
model might be finding certain relationships that are not general but found only in the training set.
In supervised learning, a labelled test set is used to represent the relationship between the input
attributes and the output [35,39]. The labelled test set allows for the construction of the confusion matrix
[40]. The confusion matrix is a table that describes a model’s performance providing the classes and how
each instance in the test set was classified. This matrix allows for the calculation of measures such as true
positive, false positive, true negative, and false negative, required to calculate the different performance
metrics such as sensitivity, specificity, and accuracy [43]. The measurements derived from the confusion
matrix are also used to calculate classifier metrics such as the receiver operating characteristic curve (ROC),
which represents the diagnostic ability of a classifier. It also allows for the calculation of the area under the
ROC curve (ROC-AUC). The ROC-AUC is defined as the probability that a randomly selected instance
from the positive class will be ranked higher than one from the negative class, and represents the percentage
of randomly selected instances correctly classified by a model. The ROC-AUC can be used to compare
classifier performance for model selection [38,41,43]. Another used metric is the Matthews correlation
coefficient (MCC) which allows the measure of quality of a binary classifier, with values ranging from -1
(disagreement between predicted and observed) to +1 (perfect prediction), with 0 representing that
prediction is not better than a random guess [44]. It is important to note that these various performance
measurements of classifier performance can also be calculated during validation, using the different folds
that were split from the training set, depending on the cross-validation method.
In supervised machine learning, one potential issue is model over-fitting. The effects of model overfitting are generally observed when comparing the performance of the model with the training set and the
test set. An over-fitted model performs well on the training set but poorly on the test set [34]. In other
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words, the model has learned the training data well, but when presented with an unseen test set, its
performance will be below expected [33,34,36]. Thus, the difference in model performance between
training and test sets can be used to identify over-fitting. If significantly higher performance is observed in
the training set than in the test set, it is possible that the model might be over-fitted [40]. Model over-fitting
can be caused by background or noisy data during model construction [41]. Another possible source is the
absence of data points which can result in the model attempting to classify instances by using uninformative
features. These possible causes of over-fitting can be handled using methods such as feature selection
[45,46] and class-balancing approaches which have been reported to address the drawback of model overfitting and thus improve classifier performance [47,48].

1.2.2 Feature Selection in Machine Learning
Feature selection for classifier construction is the process by which attributes used to encode data
instances are selected to generate an optimal feature subset [27]. This process is undertaken in the following
manner: given a dataset with A features, the goal is to generate a new set B, where B⊂A, meaning that B is
a subset of A [45]. The idea of feature selection is based on the concept of dimensionality reduction.
Dimensionality reduction removes irrelevant features and reduces the feature set. A reduced feature set can
lead to reduced computational time for classifier construction, reduction in computational cost for the
calculation of the function between the input attributes and the class [49], and possible improvement of
classifier performance [35,50].
In a dataset with a large number of attributes, it is possible that certain attributes are uninformative.
This can lead to over-fitting [35,51]. By selecting the attributes that provide valuable information and
discarding those that are background noise [45,52], it is possible to increase model performance [46] and
prevent over-fitting, as irrelevant features could lead to spurious conclusions [50,51]. The incorporation of
irrelevant features may create irrelevant relationships between features and response variables, leading to
models that have reduced generalization.

9

Feature selection can be used to extract important information from the dataset, providing
significant insights into the data [53]. This is of special interest in knowledge discovery where identification
of significant features within a dataset can also be useful to further the understanding of what attributes
could be of importance in the association, causality, or development of a biological process; for example,
it can identify important developmental stages associated with diseases such as autism, or identify risk
factors associated with cancer [30,35,54,55].
Feature selection methods can also be used in knowledge discovery to extract new and valuable
information from biological datasets. By applying feature selection methods, it is possible to use the
variables selected as a source of new biological knowledge [53]. For example, Cogill and Wang [30] used
feature selection to identify spatiotemporal expression features from the developing brain associated with
autism spectrum disorder (ASD), providing new insight into critical stages of development for ASD. It is
also possible to compare feature selection methods to identify overlapping or commonly identified features.
The overlapping variables identified by different methods can provide important insight regarding the
dataset, such as association with a disease. For example, Liu et al. [56] used the overlapping features from
proteomic data in an ovarian cancer association study.

1.2.3 Handling Class Imbalance in Machine Learning Problems
Imbalanced datasets are common for machine learning, and more often occur in biological cases
[20,57]. The presence of class-imbalanced datasets in the biological context can be found in target gene
prediction, disease gene discovery, binding site prediction, and pre-miRNA prediction [47,57], where the
targets are generally an underrepresented class. To address this potential problem, several possible solutions
have been proposed at the data-level as well as at the algorithm level [33,58,59]. The sampling techniques
used to address the class imbalance problem or the class distribution problem in a dataset involve artificial
re-sampling of the dataset. This can be achieved in two ways: under-sampling of the majority class, or over-
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sampling of the minority class [33,58–60]. It is also possible to combine both the re-sampling approaches
to pre-process the data to handle class imbalance in the dataset.
Algorithmic approaches include parameter modifications, such as the class weight adjustment to
counter class imbalance, decision threshold adjustment, and recognition-based learning instead of
discrimination-based learning [58,60]. Algorithmic approaches can be used in combination with data-based
approaches. The combination of algorithmic and data-level class-balancing methods is known as mixtureof-experts. Mixture-of-experts approaches combine the results from multiple classifiers using oversampling, under-sampling, or fine-tuning of the class weights. We will next briefly discuss those methods
at the data level used in handling imbalanced datasets [33,58–60].

1.2.3.1 Under-sampling Techniques
Under-sampling methods randomly select instances from the majority class to balance the dataset.
By reducing the instances in the majority class, random under-sampling improves classifier performance,
reducing the classification bias introduced when a class is over-represented [33,58]. It has been reported
[57] that the use of under-sampling techniques with multiple machine learning algorithms has been
successful in pattern recognition and classification tasks. However, one potential problem associated with
random under-sampling techniques is the loss of significant data instances, which can lead to loss of
information. To address this potential issue, more advanced under-sampling methods have been developed,
including Tomek links [33,58–60].
The under-sampling technique consisting of forming Tomek links between pairs of data instances
identifies the minimally distanced nearest neighboring instances from different classes. The majority class
instances are subsequently removed to balance the classes. The definition of a Tomek link is given by
[33,61]: two data instances, Ei and Ej, each belonging to a different class, have a distance defined by d(Ei,Ej).
The pair of data instances (Ei,Ej) will be identified as a Tomek link pair unless, another instance, El, changes
d(Ei,Ej). If d(Ei,El) < d(Ei,Ej) or d(Ej,El) < d(Ei,Ej), then Ej and Ei will no longer be considered Tomek links.
11

For class balancing, the data instance from the majority class forming a Tomek link pair is removed from
the balanced dataset. This strategy can be effective in addressing the over-representation of the majority
class, and has been reported to handle the issue of loss of informative data instances associated with random
under-sampling [57,61]. However, previous studies report that Tomek links as with other under-sampling
strategies are more effective when combined with over-sampling approaches, and their model performance
improvement capabilities have been observed when combined with synthetic over-sampling of the
minority-class technique (SMOTE) [33,61].

1.2.3.2 Over-sampling Techniques
Over-sampling methods randomly create new instances from the minority class [33,58,59,62].
Over-sampling may lead to model over-fitting due to over-representation of data instances. Overrepresentation refers to creation of new data instances from a single data instance [57,62]. The new data
instances will have the same attributes as the data from which they were generated. Although the data set
is balanced, it does not represent the distribution of the attributes of the minority class. The use of oversampling can result in model over-fitting [57,62]. To prevent over-fitting, over-sampling should not be used
on the validation split, and should only be used in the training set. The use of over-sampling methods can
be considered a data pre-processing step, which, depending on the size and dimensionality of the dataset,
could prove a computationally exhaustive task [33,62]. However, over-sampling does have its advantages
over under-sampling methods. Contrary to under-sampling, over-sampling does not reduce the majority
class, ensuring no loss of informative instances [47,48,63]. Over-sampling methods can also generate new
samples not only from existing data instances but also from the lines joining multiple data instances in the
dataset. This can be used to handle the over-representation issue that can lead to over-fitting. This is
implemented in the over-sampling technique, Synthetic Minority Over-Sampling Technique (SMOTE).
The SMOTE technique balances a dataset by selecting a data instance or point and creates synthetic or new
minority class data though interpolation between an instance and its neighbors [48].
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SMOTE over-sampling occurs when new instances are generated from the line segments that
connect a selected data instance to k elements of the minority class [47,48,63], where k is the number of
neighboring elements used to interpolate the new synthetic samples. Figure 1.1 illustrates the process of
generating synthetic samples, where xi is the selected data instance and xi1 to xi4 are the nearest neighbors.
In the figure, r1 to r4 are the randomly generated synthetic data points created from interpolation. SMOTE
handles possible over-fitting by generating new samples from the line between the data point xi and
randomly selected nearest neighbors, thus avoiding over-representation.
In over-sampling, the creation of exact replicates from data instances lead to the decision boundary
to tighten, which can result in over-fitting. Tightening refers to the boundary being close to the minority
class. Thus, the decision boundary is far from the ideal boundary expected for class separation. In contrast,
the synthetic data instances generated from SMOTE are not exact copies of any existing instance; this leads
to a softer decision boundary. In this case, the decision boundary is closer to the ideal boundary for class
separation. This reduces the effects of over-fitting [48,61,63]. In this dissertation, SMOTE was used on a
dataset comprising intellectual disability (ID) genes and non-ID disease genes. The use of this method
improved model performance.
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Figure 1.1 Illustration of how SMOTE creates new synthetic instances. The initial selected data point xi
has a set of neighbors defined as xi1-xi4. The algorithm creates lines that join the initial data point with the
neighbors and within these segments the new synthetic samples are interpolated. The image was used from
Lopez et al. (2009) [63] with permission.

1.3 Intellectual Disabilities and Long Non-coding RNAs
1.3.1 The Etiology of Intellectual Disabilities
Intellectual Disability (ID), formerly known as Mental Retardation (MR), refers to a large
heterogenous group of disorders that have the impairment in intellectual abilities as a common trait. ID has
a prevalence in the population of 1-3% [64,65], with severely affected individuals representing 0.3%, and
approximately 85% classified as mild ID patients. Individuals with ID are usually diagnosed prior to the
age of 18 years with an intellectual quotient (IQ) of below 70 [65,66], and limited adaptive behaviors such
as self-care, communication, and social skills [65,67]. ID can be classified using the level of impairment
on the IQ: profound (IQ<20), severe (IQ 20–34), moderate (IQ 35–49) and mild (IQ 50–69). A more
simplified classification scale can be used, where severe ID includes all IQ values below 50 and mild ID
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refers to all IQ values between 50 and 70 [65]. Although ID represents a lifelong impairment, there have
been studies reporting the use of cognitive training in individuals with mild ID [67], stimulated their
working memory and attention, improving their abilities in tasks such as self-care or speech. However, the
challenges for individuals afflicted with severe ID remains, as they will require constant care for the rest of
their lives.
ID disorders can also be classified as syndromic or non-syndromic [66]. This distinction is based
on the presence of other manifestations associated with ID. In syndromic ID, individuals diagnosed with
ID commonly present dysmorphic traits or metabolic disorders. In non-syndromic ID, the intellectual
impairment is the only manifestation [64–66]. It is possible for a non-syndromic ID to be re-classified as
syndromic; for example, OPHN1, a non-syndromic ID gene located on the X-chromosome (XLID), was
later identified to be associated with cerebellar hypoplasia through magnetic resonance imaging, causing it
to be re-classified as a syndromic ID gene due to the presence of an associated malformation [65]. Both
syndromic and non-syndromic ID can be caused by genetic and exogenous factors. Exogenous or external
elements have an impact on the development of ID, with some factors like fetal alcohol syndrome, pre- and
postnatal infections and peri- and postnatal asphyxia, amongst others, causing approximately 25-50% of
reported mild ID [64,65]. However, for moderate to severe ID, approximately 65% of ID cases have a
genetic etiology [65,68]. In cases where genetics is the main cause of ID, the genomic abnormalities leading
to ID are chromosome aneuploidy as in Down syndrome, or structural abnormalities, such as chromosomal
deletions in cri du chat syndrome, or monogenic (single-gene) ID, as in fragile X syndrome [65].
Previous studies have identified structural variations as a cause of ID [69]. These structural
variations refer to chromosomal regions larger than 1 kilobase (kb) that include inversions, translocations,
and copy number variants (CNVs) [65,66]. Chromosomal translocations are exemplified by the
Robertsonian translocation, associated with chromosomes 14 and 21, where the chromosomes break at the
centromeres and the q (long) arms of both chromosomes fuse to form a larger chromosome. Individuals
with this kind of unbalanced translocation carry a trisomy at chromosome 21, that leads to Down syndrome.
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CNVs are defined as insertions or deletions in a stretch of DNA that are >1 kb, and up to several megabases
(Mb) in length [66]. It has been reported that for ID, the association of CNVs with ID causality is estimated
to be ~14%, with some of these CNVs being >400 kb [69]; however, as more de novo CNVs are identified
this number could change. CNVs have been associated with both syndromic and non-syndromic ID, and
have been identified through whole genome sequencing in multiple chromosomes, including chromosomes
4, 15, 17, and X [70].
Monogenic ID have been mapped across the human genome in both autosomal and the X
chromosome [65]. Notably, X-linked ID (XLID) genes have been identified to represent 10-15% of known
protein-coding ID genes in the genome [68]. There are ~100 known XLID genes, representing
approximately 10% of the known protein-coding genes (800) for the X chromosome. Overall, the number
of ID genes in the genome represents ~4% of all protein-coding genes, based on the estimate that there are
~19,000 protein-coding genes in the human genome [68,71]. Currently, the number of known proteincoding ID genes is 818, including genes that overlap with other cognitive disorders [65] .
Previous studies have reported that ~40% of individuals affected by an ID are also affected by
another cognitive disorder or intellectual impairment [65,66]. The report by van Bokhoven [65] suggests
that there is evidence of comorbidity between ID and cognitive disorders such as autism spectrum disorder
(ASD). However, not all ID genes overlap with cognitive disorders; ~450 genes have been identified to
uniquely manifest ID. The importance of monogenic ID was identified to be the second cause of ID after
Down syndrome in a study of 4,730 children affected by intellectual and cognitive impairments [72].

1.3.2 The Study of Intellectual Disability-Causing Mutations and Phenotypes
The identification of disease-causing mutations is the result of genotype-phenotype association
studies, where the effect of a mutation on the clinical manifestation is analyzed [65]. These studies are
focused on analyzing individuals affected by a disease, such as a syndromic or non-syndromic ID, to
discover the mutation that caused the development of the phenotype being characterized. Mutations at
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different positions in a gene can result in very similar phenotypic manifestations; for example, in SnyderRobinson Syndrome (MRXSSR), an XLID caused by mutations in the spermine synthase (SMS) gene, where
two identified mutations (V132G and Y328C) led to mild forms of ID with similar phenotypic
manifestations [73,74]. In other cases, mutations in the same position can generate different phenotypes,
such as in Alpha Thalassemia Mental Retardation X-Syndrome (ATRX), where the R246C amino acid
change, which represents 36% of all ATRX mutations, causes the development of diverse phenotypes
including various degrees of ID (moderate to severe) and urogenital defects [75]. The examples of MRXSSR
and ATRX demonstrate how it is possible to associate mutations in ID genes with clinical manifestations of
a disorder. However, these examples show that it is also possible for other factors, including the
environment, to affect the phenotypic manifestations of ID.
The identification of the mutations associated with the phenotype include familial studies that focus
on the individual’s relatives as well as other affected families. Other analyses are histochemical and
biochemical assays on the tissues, which are followed by molecular genetics analyses. Familial studies are
used to identify the possible mode of inheritance of a disease, but also to study multiple affected families
to determine possible environmental effects on disease manifestation. The importance of familial studies
can be exemplified in the identification of ATRX where 80 unrelated families with affected children were
studied to identify the mutations associated with the disorder [76].
The use of histochemical, biochemical, and molecular genetics assays can identify the presence of
ID-causing mutations. Each approach generates different information about the mutation, which when
combined can provide a better understanding of the cause of the ID phenotype. For example, histochemical
reactions have shown that phenotype-associated mutations were identified in mitochondria and not the
nucleus. Subsequently, molecular genetics was used to identify the mutation as an insertion within in the
mitochondrial gene COX3 [77]. More recently, techniques such as whole genome sequencing, which have
become more accessible, have been used in the identification of CNVs and their association with ID
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phenotypes [70]. This approach has made it possible to identify disease-causing mutations previously
undetected by other methods.
Computational methods can be used to facilitate the identification of ID-causing mutations.
Statistical coupling analysis (SCA) is a method based on multivariate statistics, and can be used to find
amino acid positions in a protein that are associated with ID phenotypes [78]. SCA identifies groups of
residues within a multiple sequence alignment that share an underlying relationship [79,80]. This
relationship is defined as co-evolution, and has been described as coordinated changes in pairs or groups of
residue positions [80]. The groups identified by SCA are denominated sectors and represent clusters of
amino acids that are functionally important, and if mutations occur within sector residues, protein identity,
such as activity, substrate affinity, or stability, may be affected [79]. Protein sectors differ from functional
units such as domains, as protein sectors are not necessarily found in sequential amino acid positions, or in
continuous blocks of residues [78]. Although residues in a sector might not be continuous, when a protein
folds, the seemingly distant positions may interact with each other [79].These interactions in the protein
structure support that co-evolution between residues is necessary to maintain protein function.
The effect of mutations in sector residues was reported by Halabi et al. [79]. The authors analyzed
the results of site-directed mutagenesis on sectors associated with catalytic activity and thermal stability.
These experiments resulted in reduced enzymatic activity and thermal stability. The study also reported that
each sector was functionally independent, meaning that mutations in residue positions of one sector caused
one phenotype, and mutations on another sector caused a different phenotype [79]. Protein sectors can
identify new sites of functional importance on the protein. Previous studies [79,81,82] have reported that
residues in a sector represent functional positions, with characterized phenotypes when mutated. Further
insight can be obtained by analyzing the uncharacterized residues within a sector. These positions, when
mutated, are expected to have similar effects on protein function. This characteristic of SCA can provide
valuable information into the study of mutations and phenotypes in ID and other diseases. SCA can be used
to identify new functionally important sites in a sector associated with distinct ID phenotypes. These sites
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are expected to have similar phenotypic manifestations as the known sites clustered within the sector. The
use of SCA to cluster disease-causing mutations in an ID protein [83] has shown that it is possible to
associate different phenotypic manifestations in syndromic ID with different protein sectors.

1.3.3 Intellectual Disability-Causing Genes
Previous studies have suggested that there may be ~800 protein-coding ID genes [71]. Of those
genes, it was reported that ~450 were ID-causing genes with no overlap with other intellectual or cognitive
impairments, with 400 being associated with syndromic disorders and ~50 causal of non-syndromic ID
[65].

More

recently,

the

Intellectual

Disability

Gene

Database

(http://gfuncpathdb.ucdenver.edu/iddrc/home.php) annotated 484 ID-causing genes. Notably, 95 of the
protein-coding genes, representing ~19% of the list, were located on the X chromosome, a percentage
similar to the number of known XLID (~15% of all protein-coding ID genes) [68].
The entries in the ID Gene Database have been curated to provide functional information about the
observed manifestations that have been described through association studies and various mutations
reported for the phenotypes. The effect of mutations on phenotypes can be accessed through the provided
Online Mendelian Inheritance in Man (OMIM) entry number [84]. For example, SMS has the OMIM entry
300105 in the ID Gene Database, which can be used to access OMIM to retrieve information about
mutations and the phenotypes causing Snyder-Robinson syndrome, as well as other valuable information
such as literature and molecular genetics of the disease.
In the last decade, the regulatory functions of non-coding RNA genes in gene expression have been
analyzed in many studies [85–87], expanding our knowledge on the importance of what was previously
described as “junk DNA”, due to our lack of understanding of its role and potential functions [88]. Previous
studies have described the importance of non-coding RNAs, especially long non-coding RNAs (lncRNAs)
by reporting their regulatory roles [89], tissue specificity [87], and evolutionary importance in mammalians,
as well as their potential involvement in ID [90]. The works by Loohuis et al. [91] and van de Vondervoort
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et al. [90] also have been of importance in understanding how lncRNAs are potential ID candidates. In their
studies, the authors report that a significant number of lncRNAs are found in the brain, although for the
exception of a few examples (UBE3A in Angelman syndrome, BC1 in fragile X syndrome amongst others),
the functions of most lncRNAs remain to be elucidated. A recent study by Chiurazzi and Perozzi [71]
emphasized the importance of lncRNAs and other non-coding elements as ID candidates [92]. In this
section, we have described ID-causing genes and focused on the role of protein-coding genes in ID
causality. In section 1.3.6, we will discuss the potential involvement of lncRNAs in ID pathogenesis.

1.3.4 Overview of Long Non-Coding RNAs
Long non-coding RNAs (lncRNAs) are non-coding transcripts, >200 nucleotides, with relatively
low conservation [85,86,92]. Previous studies [85,86,93,94] reported the structural similarities that
lncRNAs share with messenger RNAs, with most of these non-coding transcripts having a 5’ cap, being
polyadenylated, and spliced. However, lncRNAs do not have open reading frames with protein coding
potential [85,87,95,96]. Another interesting aspect of lncRNAs is their low abundance, high tissue
specificity, and low evolutionary conservation when compared to protein-coding mRNAs. Because of their
lower overall expression, it is more difficult to identify and quantify lncRNAs than protein-coding mRNAs
[87,97,98].
The annotation of genomic elements has been a task endeavored by the GENCODE project [99].
This has included the identification of lncRNAs. Although lncRNAs, as with other non-coding elements,
were initially part of what was considered “junk DNA” or termed the “dark matter” of the genome due to
lack of knowledge associated to its function [97], it was later revealed that lncRNAs as well as other noncoding elements are essential to the regulation of developmental processes in complex organisms
[68,87,89]. The annotation of lncRNAs in GENCODE 7 (2010), manually curated using the HAVANA
manual curation protocol, identified 9,640 lncRNAs within the human genome. However, it was estimated
that this number would only increase as more lncRNAs were expected to be discovered in subsequent
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releases of GENCODE. For the 2011 release of GENCODE, identified as GENCODEv10, the number of
lncRNAs was 10,840, corroborating their initial assessment that the number of such elements was only to
become greater with each subsequent release. The current version of GENCODEv21 (2014) reports 15,877
lncRNAs (http://www.gencodegenes.org/stats.html). The increase in the number of lncRNAs demonstrates
that the actual number of lncRNAs in the human genome could surpass the number of protein coding genes.
When GENCODEv7 was released, lncRNAs were classified as belonging to a specific biotype.
This classification was based on the lncRNAs’ positions with respect to protein-coding genes on the genome
[99]. These biotypes were defined as antisense RNAs, lincRNAs, sense overlapping, sense intronic, and
processed transcripts [99,100]. Antisense lncRNAs refer to transcripts that intersect either introns or exons
of protein-coding genes or have evidence of antisense regulation of a coding gene. LincRNAs are defined
as long intervening non-coding RNAs, with an evolutionarily conserved genomic architecture in vertebrates
that consists of 2-3 exons that are slightly longer than protein-coding genes, with most of them
polyadenylated. Sense intronic RNAs are defined as transcripts within introns of a coding gene found not
overlapping any known exons. Another biotype of lncRNAs is the processed transcripts, which according
to the GENCODE biotype definition [99] do not contain an open reading frame and cannot be placed in
any other biotypes. The biotypes have continuously been expanded to include more lncRNAs as they are
identified [100]. Amongst the new lncRNA biotypes are: macro lncRNAs, which are mostly unspliced
transcripts that are >10 kb in length, and bidirectional promoter lncRNAs, referring to those originating
within the promoter region of a protein-coding gene. These biotype definitions were used in this dissertation
to generate a list of lncRNAs to identify candidate intellectual disability-associated long non-coding RNAs
using an expression-based machine learning classifier [99,100].

1.3.5 Mechanisms of LncRNA Function
The functional characterization of lncRNAs is still a major challenge. However, based on those
whose function has been elucidated, it has been suggested that they can interact with DNA, RNA, and
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proteins (Figure 1.2). Previous studies [95,96,101] have identified that the regulatory interactions of
lncRNAs occur through base-pairing with short stretches of RNA, structural domains in the chromosome,
in the case of chromatin remodeling, and also by acting as an allosteric regulator in regulation of
transcription factor binding to DNA [86]. The possible mechanisms of action of lncRNAs include molecular
scaffolds, which bring two or more proteins into a complex or physical proximity. These protein complexes
can have trans regulatory effects on the DNA, which can lead to chromatin remodeling. These chromatin
remodeling complexes can have important effects on gene activation or silencing, modifying the expression
landscape, especially during developmental stages [86]. LncRNAs can act at the transcriptional level as
RNA decoys, which act as target mimics, diminishing the ability of transcription factors to bind to their
DNA-binding sites; for instance, it has been noted that splicing events can be regulated by the action of
lncRNAs [86,96]. Also, lncRNAs can regulate mRNA translation. A previous study [102] reported that
lincRNA-p21 is involved in translational regulation of mRNAs JUNB and CTNNB1 by associating with
translational machineries [102]. LncRNAs can also have an effect on the levels of microRNAs (miRNA),
as miRNA sponges. The miRNA sponge acts as a decoy for miRNA target sites, reducing the effects of the
miRNA complexes on their target mRNA [86,103,104]. The effect of miRNA sponges on miRNA
complexes is known as titration away, or a reduction of the miRNA complexes that can degrade the mRNA,
resulting in an upregulation of the levels of mRNA [86,104]. This titration effect seems to be not only
limited to miRNA, but can affect other targets such as transcription factors, as reported by Gaiti et al. [104].
LncRNAs have been shown to act in both cis and trans regulatory mechanisms, making them an important
part in developmental processes as well as transcription and translation [103,104].
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Figure 1.2 Schematic overview of LncRNA regulatory mechanisms. LncRNAs regulate gene expression
through various mechanisms that include: (1) RNA decoys, by directly binding to the transcription factors.
(2) LncRNAs can also act as microRNA sponges, to titrate away microRNA complexes from their mRNA
targets. (3) LncRNAs can act as scaffolds, within ribonucleoprotein complexes or by binding to specific
proteins. (4) LncRNAs can also recruit chromatin-modifying complexes. Other regulatory processes
include: translational regulation of mRNA (5), splicing (6), and degradation of mRNA (7). The figure was
adapted from Hu et al. (2012) [86].

1.3.6 Possible Involvement of LncRNAs in Intellectual Disabilities
It has been proposed that there is a correlation between the diversity of non-coding elements and
the evolutionary divergence and complexity of organisms [87,90]. Evolutionary studies have identified that
lncRNAs have low conservation at the sequence level. However, studies indicate that for higher animals
(metazoans), lncRNAs have been important in the development of cognitive complexity, especially in the
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mammalian and primate brains [87,89,90]. In fact, it has been reported that spatiotemporal expression
patterns of lincRNAs in the prefrontal cortex of the brains of macaques and humans in comparative studies
showed to be as conserved as those of protein-coding genes [89]. This has suggested that lncRNAs could
be playing an important role in neurodevelopmental processes, and perhaps in cognitive development.
Previous studies [65,89] have identified that lncRNAs could be associated with neuronal diversification as
well as specification of individual neuronal subtypes. It is also possible that lncRNAs could be associated
with disease in the human brain due to their role in gene regulation [89], and neurodevelopmental disorders,
which could include intellectual disabilities amongst such diseases.
This possible association was explored in previous studies [90,91], which analyzed the effect that
non-coding genes, such as lncRNAs, had on the deregulation of transcription and translation and their
impact on ID gene expression and phenotype manifestations. Deregulation of non-coding transcripts in
neurodevelopmental disorders was supported by the observation in Loohuis et al. [91], where miRNA were
identified to regulate the expression of mRNAs in axosomal and the synaptodendritic compartments. The
possible association between deregulation of miRNA and lncRNAs can be established due to the role of
lncRNAs as miRNA sponges, titrating away the miRNA complexes that regulate mRNA translation. A
study by van de Vondervoort et al. [90] reported that a major portion of the non-coding transcripts in the
brain are lncRNAs, with a large fraction of brain-specific non-coding genes having altered levels in ID
brain tissues. Deregulation of lncRNA expression can impact ID-risk gene expression. According to the
study by van de Vondervoort et al. [90] as well as other authors [65,91], deregulation of lncRNAs can lead
to abnormal transcription and translation of ID-risk genes, potentially resulting in various
neurodevelopmental disroders, including fragile X syndrome, Down syndrome, and Angelman syndrome.
In chapter II of this dissertation, we developed an expression-based machine learning classifier that
used ID and non-ID disease genes to identify novel ID-associated lncRNAs using the developing brain
transcriptome data. Our goal was to identify novel candidates that could be used in human genetics research.
In Chapter III, a three-state SVM model was developed for predicting the effect of amino acid substitutions
on protein stability. We show the effect of feature selection on model performance. In Chapter IV of this
24

dissertation, we demonstrated the use of statistical coupling analysis to cluster amino acid residues in
protein sectors and determine the effect of mutations in these groups in the development of phenotypic
manifestations in ID. In Appendix A, we show our efforts in a collaborative study that focused on the use
of mutual information to understand the functional divergence of the UDG protein family.
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Abstract

Background: Intellectual disabilities (ID) are neurodevelopmental disorders with an estimated prevalence
in the population of 1-3%. These disorders have a complex genetic etiology, with possible involvement of
not only protein-coding genes but also non-coding elements, including long non-coding RNAs (lncRNAs).
However, the role of lncRNAs in ID is still unclear although evidence supports possible associations of
lncRNAs with disease causality and development. To identify candidate lncRNAs associated with ID,
predictive methods need to be based on gene expression patterns.
Results: We have developed an expression-based classification model using Support Vector Machines. The
model was trained using a developmental brain transcriptome dataset, with known ID-causing genes as the
positive instances and non-ID disease genes as the negatives. We used Random Forest-based methods for
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feature selection, however, this did not significantly improve model performance when compared with the
full feature set. To address the class imbalance problem, we used synthetic oversampling of the minority
class, which resulted in the best-performing model with the overall accuracy of 80.22% (76.34% sensitivity
and 83.95% specificity) in tenfold cross-validations. This model was then used to predict ~760 candidate
lncRNAs associated with ID. These candidate lncRNAs were analyzed for co-enrichment with known ID
genes in co-expression modules. We identified the co-enrichment in modules related to neurodevelopmental
and synaptic processes.
Conclusions: A new gene expression-based classifier has been constructed and used to identify candidate
lncRNAs associated with ID. The results from our analyses suggest a potential role of these candidate
lncRNAs in development and etiology of ID.

2.1 Background
Intellectual disabilities (ID) are neurodevelopmental disorders, which are estimated to be prevalent
in 1-3% of the general population [1], and are commonly diagnosed prior to 18 years of age [2]. ID patients
are associated with intelligence quotient (IQ) sores <70 and diminished cognitive abilities [1,2]. ID can be
syndromic, meaning that there are also morphological abnormalities or metabolic disorders, or can be nonsyndromic, in which the intellectual impairment is the only clinical manifestation [3]. It is also possible for
ID to be associated with other conditions such as autism spectrum disorders (ASD) [2]. This complexity of
ID is also represented in the possible causes. Although exogenous factors can influence ID causality, genetic
factors remain the major cause of ID [1–4]. To further our understanding of ID, we need to expand the
knowledge of ID-causing genes. Currently, almost all of the known ID-causing genes are protein-coding,
whereas the numerous long non-coding RNAs (lncRNAs) have not been thoroughly examined for their
possible roles in the etiology of ID [1,2,4].
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The importance of non-coding transcripts and their roles in gene expression regulation have been
expanded since their discovery, with special interest in lncRNAs and their tissue-specific expression [5,6].
These transcripts, which are more than 200 nucleotides long and are a heterogeneous group, are involved
in a variety of biological processes [7–10]. In recent years, more and more lncRNAs have been identified
and studied becoming interesting candidates that could potentially be inovlved in diseases such as
neurodevelopmental disorders or cancer. Additionally, lncRNAs have known functions such as Xchromosome inactivation in mammals [8] or interacting with chromatin remnodelling complexes [5]. A
recent study used an integrative approach to link lncRNAs with neurodevelopmental functions, and to
examine their possible associations with ID [2]. However, the extent and number of lncRNAs associated
with ID remains to be discovered, and methods capable of identifying and providing new insights into the
possible roles and number of genes involved in the causality and development of ID are necessary to further
our understanding of disease etiolog
By harnessing information from known ID-causing genes it is possible to use machine learning
algorithms to discover novel ID-associated lncRNAs. For a classification task such as this, Support Vector
Machines (SVMs) can provide accurate model building and efficient computational cost [11]. Besides the
success in predicting DNA/RNA binding residues [12] and splice sites [11,13], recent research has reported
a number of efficient and accurate SVM classifiers using gene expression data [14–16]. Moreover, SVMs
have the advantage of combining parameter optimization and feature selection methods [17, 18], and using
approaches to deal with class imbalance such as oversampling and under-sampling [19, 20]. In this study,
we developed a new SVM classifier based on developmental brain gene expression patterns to identify
candidate lncRNAs associated with ID. The idea behind this was due to the non-coding nature of lncRNAs
and thus to avoid using protein sequence-based features. We also performed gene co-expression network
analysis to further understand the possible function of these candidate lncRNAs.
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2.2 Methods
Data preparation
The developmental brain gene expression dataset was obtained from the BrainSpan website at the
Allen Institute [21]. From this dataset, the expression profiles of ID-causing genes (IDGs) and non-ID
disease genes (NIDGs) were extracted and used for classifier construction. The filtering was done based on
their known identity as either ID-causing or disease genes that are not causal of IDs. Classification of ID
genes was based on previous studies [22–24], which provided functional annotation and association of these
genes with ID. We also used the information available from the ID Gene Database Project
(http://gfuncpathdb.ucdenver.edu/iddrc/iddrc/home.php), which compiled a comprehensive list of known
ID genes. The training dataset consisted of 423 IDGs and 1830 NIDGs. A second set of expression profiles
was also extracted for brain-expressed lncRNAs. This second set was used by the classifier to identify new
candidate lncRNA associated with ID. For each dataset, the gene expression values were log2-transformed
to make the variation magnitudes amongst individual gene expression profiles similar.

Classifier training and testing
Prediction of ID-associated lncRNAs can be regarded as a binary classification problem, for which
a classifier is constructed to discriminate the belonging of an object to one of two classes – positive or
negative [11, 25]. In this case, genes are classified into either of two classes (ID or non-ID disease causing).
We used Support Vector Machines (SVMs) to develop the classifier. SVMs use two key ideas, a separation
margin and a kernel function, to solve the classification task [11, 25]. The use of SVMs in this study was
based on the reported success of SVMs in developing expression-based classification models. Previous
studies developed high-performing SVM models capable of predicting gene associations with cancer, ASD,
and neurodegenerative diseases [14, 16, 26–28]. In addition, we also tested two other machine learning
algorithms, Random Forests and naïve Bayes, for classifier construction.
In this study, the SVM classifier was developed using the radial basis function kernel. The
misclassification cost (C) and gamma parameters were optimized for classifier training. We used a two42

step grid search to find the optimal C and gamma combination. The preliminary search tested the possible
combinations of C values ranging from 0.5 to 10 with different gamma values from 1e-6 to 1. Once this
step was completed, a refining grid search was done to determine the best-performing combination of C
and gamma values. The SVM classifier was trained using the package e1071 [29] for R version 3.3.3 [30].
Model performance was evaluated initially with fivefold cross-validation and subsequently with
tenfold cross-validation. The following performance metrics were used to evaluate the models:
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In the above equations, TP = true positive, TN = true negative, FP = false positive, and FN = false
negative. The F-measure, also referred as the F1 score, is often used to evaluate models constructed from
an imbalanced dataset, and has the range from 0 (worst) to 1 (best). In this study, the overall accuracy,
sensitivity, specificity and F-measure were calculated using the performanceEstimation package [31].
Model selection was based on the Matthews Correlation Coefficient (MCC) and the area under the receiver
operating characteristic (ROC) curve or ROC-AUC. The ROC was plotted using the ROCR package [32].
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Feature selection
The reduction of redundant and noisy features to improve classifier performance were done using
two feature selection algorithms: Random Forests with the Boruta R package [33, 34] and recursive feature
elimination with the caret package [18, 35]. Each method generated a list of selected features, and the effect
of reducing the feature space on model performance was determined. For each selected feature subset, the
classifier was re-trained and tested using tenfold cross-validation to determine the performance metrics,
including sensitivity, specificity, MCC, and ROC-AUC.

Minority class oversampling
In this study, the training dataset is imbalanced, with many more NIDGs than IDGs. When models
are trained using an imbalanced dataset, there are strategies to counter the difference between the underand over-represented classes and thus increase the model’s ability to discriminate between the classes.
These strategies include the adjustment of class weights, under-sampling of the majority class, and oversampling of the minority class. Although under-sampling was shown to be effective [20], this could reduce
the information for model construction. The reduction of the majority class (NIDGs) could mitigate the
model’s ability to recognize the hidden patterns that differentiate between IDGs and NIDGs. To maximize
the amount of information for classifier construction, we used synthetic minority over-sampling technique
(SMOTE) [19, 36]. The approach computes synthetic examples of the minority class by interpolation of the
k nearest neighbors [36]. With the over-sampling percentage set to 325 and the k nearest neighbors to 5,
this operation resulted in 1835 positive instances (470 IDGs and 1365 synthetic samples) and 1825 NIDGs
in the balanced dataset for model training. The synthetic over-sampling was done with the DMwR package
[37].

Prediction of ID-associated lncRNAs
Once the model was trained, it was used to predict candidate lncRNAs associated with ID. The list
of brain-expressed lncRNAs was composed of ~9500 transcripts (SI Table 1), of potential association with
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ID. The expression dataset was log2-transformed in R. The list of lncRNA biotype definitions was obtained
using the biomaRt package in R [38] and matched to the BrainSpan gencode v10 release [39]. The lncRNAs
were identified using the Ensembl IDs [40, 41] in the further analysis.

Gene co-enrichment analysis
The co-enrichment analysis utilized a human brain gene co-expression network, which was
generated in a previous study [24] with the WGCNA package [42]. Using the module information, we
analyzed for co-enrichment of candidate lncRNAs with known ID-causing genes. For the enriched modules,
gene over-representation values were calculated using Fisher’s exact test. The resulting P-values were
adjusted to calculate the false discovery rate. To be considered as statistically significant enrichment of a
gene list, the adjusted P-value should be <0.05 and the odds ratio (calculated with Fisher’s exact test) >1.
We also compared the ID-associated lncRNAs identified in this study with a set of prioritized candidate
lncRNAs from the previous study [24]. The resulting matches were tested for statistical significance by
constructing a contingency table and using Fisher’s exact test (true odds ratio >1 and P-value <0.05).

Gene expression pattern analysis
The analysis of lncRNA expression in different tissue types was performed to determine if the
candidates were specifically expressed in the brain. We used the Genotype-Tissue Expression (GTEx)
dataset with 53 human tissue types [43]. Heatmaps were generated to compare the expression of candidate
lncRNAs in the brain and other tissues.

2.3 Results and discussion
Development of an expression-based classifier for ID gene prediction
Since the performance of machine learning algorithms may be influenced by the type of problem,
we used three algorithms, Support Vector Machine (SVM), naïve Bayes and Random Forest, to develop a
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model to discriminate between ID-causing genes and non-ID disease genes using the BrainSpan expression
data [21]. The performance metrics shown in Table 2.1 suggested that the model trained with SVM was
better suited for further optimization given that MCC and ROC-AUC were significantly higher for the
SVM. The other metrics such as the F-measure, commonly used for imbalanced datasets, as well as the
sensitivity and specificity (Table 2.1) also supported our conclusion regarding the SVM’s ability to predict
ID genes based on developmental brain gene expression profiles.
Feature selection was previously shown to improve model performance by reducing redundancy
and background noise [17, 33]. We thus compared the performance of classifiers constructed using the full
feature set and feature subsets selected by Random Forests. However, for the prediction of ID-causing genes
using expression profiles, feature selection did not significantly improve the predictive power (Table2.2
and Figure 2.1). When comparing the full feature set model (SVM_Full) and the selected feature model
(SVM_176), they had similar MCC and ROC-AUC, whereas the measurements for accuracy, sensitivity
and F-measure were better for the full feature set model (Table 2.2). The results suggest that developing an
accurate model for ID gene prediction may need the full feature set with 524 features representing gene
expression at various developmental stages and brain regions. This is consistent with ID as complex genetic
disorders and that ID diagnosis can occur until 18 years of age [1, 2].

Balancing the dataset by synthetic oversampling of the minority class improves model performance
Imbalanced datasets are commonplace for machine learning problems in biology [11, 44]. The
effect of having differentially represented classes on model performance is well known [44]. Because of
this, various strategies have been developed to counter the bias of an over-represented class in the dataset
during model construction. Initially, we used the adjustment of the class weight parameter for training SVM
models based on the ratio between IDGs and NIDGs (~1:4), assigning more weight to the under-represented
class. We expected this to improve model performance. However, that was a rather simple technique, and
we explored the possibility of applying a more advanced method to our imbalanced dataset.
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We selected the synthetic minority oversampling technique (SMOTE) [19, 36] to balance the
training dataset in this study. By using the available instances of the under-represented class, IDGs in this
case, SMOTE could derive synthetic samples from the existing IDGs. This approach was deemed
appropriate as there was no loss of information about either class, and we expected that new ID genes could
have similar expression patterns as the synthetic samples. The ability of SMOTE to maximize the use of
class information was a critical factor in balancing method selection when comparing it to other approaches,
especially with under-sampling, where selection of a subset of NIDGs would have allowed to balance the
dataset with the possible outcome of losing some information about the hidden pattern in the NIDGs.
The model constructed using the SMOTE-balanced dataset with the full feature set performed better
than the classifier built through the class weight adjustment (Table 2.2 and Figure 2.1). The performance
metrics such as MCC and ROC-AUC indicate that class balancing provided the better approach for
constructing an accurate model. Implementation of SMOTE was also found to be more effective for model
performance improvement than feature selection in this study. However, the use of oversampling alone did
not ensure high model performance, as observed when comparing the full and reduced feature sets with
balanced classes (Table 2.2 and Figure 2.1). Therefore, the model constructed using the balanced dataset
with all 524 spatiotemporal expression features achieved the best performance, and was used to predict new
candidate lncRNAs associated with ID.

Identification of new candidate lncRNAs associated with ID
The fine-tuned SVM model was used to predict 767 possible ID-associated lncRNAs from a list of
~9500 lncRNAs within the BrainSpan dataset [21]. These candidate lncRNAs were subsequently analyzed
for co-enrichment with known ID genes based on the results from a previous study [24], in which a brain
gene co-expression network was created to identify the ID gene-enriched modules. We examined whether
the possible ID-associated lncRNAs were co-enriched in any of these modules that were associated with
neurodevelopmental functions. The analysis revealed statistically significant co-enrichment in two
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modules, the purple module and the greenyellow module (Figure 2.2). These two modules were enriched
for Gene Ontology [45, 46] terms associated with biological processes including neuron differentiation and
synapse organization (Table 2.3). We also compared the list of candidate lncRNAs predicted in this study
with the list of ID-associated lncRNAs previously published by Gudenas et. al. [24], identified using coexpression networks to determine if there was a significant overlap between the two lists. We identified 55
common ID-associated lncRNAs (SI Table 2) across multiple modules, including the purple module and
the greenyellow module. Representative overlapping lncRNAs from the co-enriched modules are shown in
Table 2.3. Although gene co-expression analysis has been used to predict the possible lncRNA
functions/roles, it is important to note that co-expression is not synonymous to causality [47]. There are
some caveats with the guilty-by-association approach; however, it may provide some insights about the
candidate lncRNAs and pathways associated with ID.
Next, we utilized the GTEx dataset [43] to examine the expression patterns of the candidate
lncRNAs. Notably, the possible ID-associated lncRNAs overlapped with those from the previous study [24]
were expressed in various brain regions (Figure 2.3). We also observed a higher expression of lncRNAs in
testes, which is not unexpected, as it has been reported that testes followed by neural tissues, and in some
species the ovary, are where the largest amount of lncRNAs are expressed [48]. We also identified
expression of lncRNAs in the pituitary gland, which is expected as these genes have a regulatory role in the
endocrine system [49]. Primate brain studies have discovered significant numbers of lncRNAs expressed
in different developmental stages in brain regions like the prefrontal cortex. The degree of specificity in the
expression patterns appears similar to those of protein coding genes [50]. The relatively high expression of
the ID-associated lncRNAs in brain regions (Figure 2.3) is in accordance with their possible function in
neurodevelopmental processes.
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2.4 Conclusions
We have developed a new machine learning model for genome-wide identification of candidate
ID-associated lncRNAs using brain gene expression profiles. Three different learning algorithms were
examined for model construction. Using a training dataset of ID genes and non-ID disease genes encoded
with spatiotemporal expression features, we developed and compared the performance of these models. The
SVM model was selected due to its high performance, and then used for fine-tuning to further improve its
accuracy. Next, feature selection and class balancing methods were implemented to improve model
performance. For ID gene prediction using expression data, synthetic oversampling of the minority class to
address class imbalance, but not feature selection, was found to significantly improve model performance.
Finally, the best-performing SVM model was used to predict 767 possible ID-associated lncRNAs, which
were then analyzed for co-enrichment with known ID genes in co-expression modules. We identified 55
candidate lncRNAs that were co-expressed with known ID genes and showed relatively high expression in
various brain regions. These lncRNAs could serve as high-priority targets for experimental investigation
into the roles of lncRNAs in brain development and ID pathogenesis.
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Tables

Table 2.1 Performance of the SVM, Naïve Bayes, and Random Forest models based on tenfold crossvalidation. The models were constructed using the full feature set composed of 524 spatiotemporal
expression features.

SVM
Naïve
Bayes
Random
Forest

Accuracy

Sensitivity

Specificity

F-Measure

MCC

AUC

70.61%

70.48%

70.65%

0.8046

0.3562

0.7630

64.98%

64.62%

65.12%

0.4286

0.2582

0.6573

79.34%

10.88%

96.93%

0.1756

0.1376

0.5414
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Table 2.2 Performance of the SVM models after feature selection and synthetic oversampling of the
minority class (SMOTE). The models were constructed using the full set of 524 features or the reduced
set of 176 features as indicated.

SVM_Full

Accuracy

Sensitivity

Specificity

F-Measure

MCC

AUC

71.66%

73.42%

64.64%

0.8046

0.3562

0.7630

80.22%

76.34%

83.95%

0.7902

0.6466

0.8747

70.61%

70.48%

70.65%

0.4947

0.3630

0.7651

75.62%

82.74%

68.21%

0.7765

0.5662

0.8362

SVM_Full_
SMOTE
SVM_176
SVM_176_
SMOTE
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Table 2.3 List of selected candidate lncRNAs from this study. These ID-associated lncRNAs were also
identified in a previous study [24], and co-enriched with ID genes in brain co-expression modules.
Additional information from [24] includes the type of copy number variant (CNV), the highest
correlated ID gene, and the enriched GO term.

lncRNA Gene

Highest

Type of

Ensembl ID

Module
Symbol

CNV

GO Enrichment

Correlated
ID Gene

Term

cell

ENSG00000245864

CTC467M3.1

part

morphogenesis;
de Novo

purple

MEF2C

synapse
organization;
axonogenesis
cell

ENSG00000246477

AF131216.
6

part

morphogenesis;
Decipher

purple

PAK3

synapse
organization;
axonogenesis
cell

part

morphogenesis;
ENSG00000224855

OPA1-AS1

Decipher

purple

BRAF

synapse
organization;
axonogenesis

ENSG00000236850

LL22NC03
-80A10.6

Decipher

purple

RPGRIP1L

cell

part

morphogenesis;
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synapse
organization;
axonogenesis
cell

ENSG00000183308

AC005037.
3

part

morphogenesis;
Decipher

purple

PAK3

synapse
organization;
axonogenesis
cell

part

morphogenesis;

ENSG00000257769

CTB193M12.1

synapse
Decipher

purple

USP9X

organization;
axonogenesis

neuron projection
development;
ENSG00000228794

RP11206L10.11

de Novo

greenyellow

MBD5

neuron
differentiation;
neuron
development
neuron projection
development;

ENSG00000093100

XXbacB461K10.4

Decipher

greenyellow

RALGDS

neuron
differentiation;
neuron
development
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neuron projection
development;
ENSG00000233058

AC046143.
7

Decipher

greenyellow

MBD5

neuron
differentiation;
neuron
development
neuron projection
development;

ENSG00000254635

RP11164A7.1

de Novo

greenyellow

CEP290

neuron
differentiation;
neuron
development
neuron projection
development;

ENSG00000188242

CTD2228K2.5

Decipher

greenyellow

PPOX

neuron
differentiation;
neuron
development
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Figures

Figure 2.1 ROC curves of the SVM models constructed using the full and reduced feature sets in
combination with the SMOTE method to overcome class imbalance.
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Figure 2.2 Co-enrichment of lncRNAs and ID genes in brain co-expression modules. The modules were
obtained from a previous study [24], and the co-enrichment was identified for two modules, purple and
greenyellow. IDG stands for the possible ID-associated lncRNAs, ID for the known ID genes, and NIDG
for non-ID disease genes. The numbers in the boxes represent the odds-ratio from Fisher’s exact test.
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Figure 2.3 Expression patterns of the ID-associated candidate lncRNAs. The lncRNA candidates were coenriched with ID genes in brain co-expression modules from a previous study [24]. The GTEx dataset [43]
was used to examine lncRNA expression in different tissues, including brain (highlighted in blue).
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Abstract

Amino acid substitutions can have significant and deleterious effects on proteins. Prediction of the
effects of substitutions on protein stability has been explored, but many studies make use of structure-based
features, which are not available for all proteins. In this study, we have developed a sequence-based SVM
model for three-state protein stability prediction. This model used features extracted from the primary
sequence, and feature selection identified the most informative feature set for model construction. We
evaluated this model with an independent test dataset, and obtained the accuracy of 70.52% with 61.20%
sensitivity and 79.84% specificity. Our results suggest that sequence features contain sufficient information
for accurate prediction of three-state protein stability changes caused by amino acid substitutions.
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Keywords: Amino acid substitutions, three-state protein stability prediction, sequence features, support
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3.1 Introduction
Disease-causing sequence changes have been identified for many human genes [1–3]. The type of
changes varies in nature, affecting multiple mechanisms from RNA processing to post-translational
modifications. However, it has been identified that the most common effect of these changes is on protein
stability [1–3]. An analysis of human single nucleotide polymorphisms (SNPs) revealed that ~80% of
disease-causing amino acid substitutions affect protein stability [3]. In humans, ~60% of single nucleotide
missense mutations in coding regions account for monogenic diseases based on the Human Gene Mutation
Database [4]. Thus, understanding the effects of sequence variations on proteins is an important task.
Variations in the amino acid sequence can impact the physicochemical characteristics of a
polypeptide. These sequence changes may alter the biochemical properties of the protein, resulting in
modified structural characteristics with deleterious effects. The notion of predicting the effect of amino acid
substitutions on protein stability has been previously explored [5,6]. However, our approach, similar to [7]
and more recently [8], proposes to focus on sequence-based features and avoid using any features based on
the protein structure.
The development of a three-state protein stability predictor was previously reported [9]. However,
the approach made use of structural features which require a known protein structure. This can be a limiting
factor as not all proteins have structural information available. Although computational methods are
available for protein structure prediction [10], they are not as accurate in resolution as the experimental
determination of a protein structure. The limitation of previous works in the use of structural features may
be circumvented by encoding the instances with features derived completely from amino acid sequence.
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In this study, we have developed a new three-state protein stability predictor based on sequence
features. The importance of the sequence features in model performance was examined using two feature
selection methods capable of reducing and ranking variables, random forests and recursive feature
elimination. Our three-state protein stability predictor based on Support Vector Machines (SVMs) showed
performance comparable to the currently available methods using structural information. The results
suggest that sequence features can provide useful information for predicting the effect of amino acid
substitutions on protein stability.
3.2 Methods
Data acquisition
The protein dataset was derived from that used by Capriotti et al [9] and later modified by Folkman
et al [11]. We modified this dataset to contain 68 unique protein entries whose sequences were obtained in
FASTA format from the Protein Data Bank (PDB) [12]. The sequences were subsequently subjected to
redundancy reduction with a threshold of 85% sequence similarity using BlastClust. This assured the
uniqueness of each sequence and eliminated the presence of multiple chains for a single entry. This process
also resulted in the condensation of small sequences into larger clusters. The resulting dataset contained
1,332 non-redundant instances (henceforth s1332) with information about the PDB identifier, the wild-type
position, the mutated amino acid, the substituted position, and the free energy change (ΔΔG), which was
used to determine the class label of the instance. In this study, we had three classes or states: decreased
stability (DS), increased stability (IS), and no significant change (NC). The ΔΔG thresholds used in this
study were as follows: DS if the effect of an amino acid substitution on the protein stability change ΔΔG ≤
-0.5 kcal/mol, IS if ΔΔG ≥ 0.5 kcal/mol, or NC if -0.5 kcal/mol ≤ ΔΔG ≤ 0.5 kcal/mol. For building an
independent test dataset, we selected the s238 sequence set, and subjected it to the same process as the
s1332 dataset. This test dataset contained unique entries that were not included in the training dataset s1332,
and consisted of variants representing the three different states.
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Sequence-based features
The instances in the s1332 dataset were encoded with a total of 31 sequence features using the R
package “Peptides” [13]. This study used various physicochemical and biochemical features as defined by
ExPASy in ProtParam (http://web.expasy.org/protparam/protparam-doc.html). These features include
molecular mass, amino acid composition, charge, and aliphatic index, defined as the relative volume
occupied by aliphatic side chains (Alanine, Valine, Isoleucine, and Leucine). Other features include: the
Kidera factors, which comprise 10 features derived from 188 physical properties; three different
hydrophobicity indices, obtained with three different scales (Fasman, Bull, Chothia); instability index,
based on dipeptide composition; and the Boman index, which indicates the potential of a peptide to bind to
the membrane or other proteins.

Model construction
In this study, the multiclass protein stability model was constructed using Support Vector Machines
(SVMs) with sequence-based features. SVMs were shown to produce well-performing models for protein
stability prediction in previous studies [7,8]. In its essence, an SVM model defines a separation hyperplane
that divides the space into two distinct halves. Based on the sign given by the f(x), a point will be assigned
to a given side of the hyperplane. If f(x)>0, a point will be assigned to the positive side of the hyperplane.
The soft margin can increase the performance of the classifier when compared to hard margins, and this is
achieved by allowing misclassification of some points [15]. The use of soft margins in SVMs comes as a
response to the fact that not all data is linearly separable, which is especially true with biological data [15].
The third component refers to kernels, which can be used to make the calculation process more efficient,
especially in feature spaces of high dimensionality. The radial basis function (RBF) kernel was used to
construct the SVM model in this study. RBF is one of the most widely used kernel functions in model
development and often performs well on biological data [15].
The caret and e1071 packages [16,17] available in R were used to construct the SVM model. We
examined multiple options for model construction, including multiclass SVM models, kernel functions, and
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performance metrics. The Receiver Operating Characteristic (ROC) curve, specifically the area under the
curve (ROC-AUC), was calculated using the package pROC [18]. The SVM model was also compared with
two different Random Forest (RF) classifiers, a single RF and an ensemble of RFs. The RF learning
algorithm was previously shown to perform well for protein stability prediction [19].

Feature selection
Feature or variable selection for a classification problem can have two main objectives: (1) to
identify highly important variables that are related to the response variable, and (2) to reduce the feature
space to improve the prediction of the class label [20]. An efficient feature selection method can not only
achieve these objectives, but may also combine important components such as determining importance
thresholds, variable ranking and stepwise introduction of variables into the feature set [20,21]. In this study,
we implemented a Random Forest (RF) based feature ranking method [21]. RFs are built upon decision
trees, with every node being a condition on a variable. We also tested the recursive feature elimination
method [22], in which the lowest 20% features were eliminated in each round to determine the most
important sequence-based features.

Model performance evaluation
Model performance was evaluated using the R package performanceEstimation [23]. We used the
tenfold cross-validation method. Briefly, this method consists of partitioning the data into different folds
where one-fold is used for testing and the remaining folds are used for training. We also used the
independent test dataset s238 to evaluate model performance. The following metrics were used in this study
to measure model performance:
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Sensitivity =
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The accuracy provides the information regarding the true positives (TP) and true negatives (TN) in
the total of the dataset, which also includes the identified false positives (FP) and false negatives (FN).
Sensitivity or true positive rate refers to the proportion of positive instances that were properly identified
in each class, whereas specificity or true negative rate is the number of negative instances identified as such.
The Matthews Correlation Coefficient (MCC) was also used in this study to measure the performance of
multi-class models. For a model with three classes (A, B and C), the values for TP, TN, FP and FN can be
calculated as described previously [23]:
TP = TPA + TPB + TPC

(5)

TN = TNA + TNB + TNC

(6)

FP = FPA + FPB + FPC

(7)

FN = FNA + FNB + FNC

(8)

3.3 Results
Prediction of three-state protein stability changes
To develop an accurate model for three-state protein stability prediction, we tested two widely used
machine learning algorithms, Support Vector Machine (SVM) and Random Forest (RF). The SVM and RF
models were constructed using 31 sequence features. As shown in Table 3.1, the SVM method
outperformed the RF learning algorithm for predicting protein stability changes. The SVM model that was
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fine-tuned with the training parameters (C = 15, gamma = 0.40) achieved higher performance measures
than the RF models in the tenfold cross-validation. In this study, we constructed two RF models: a single
RF model and an ensemble comprising of three RFs (RF-E). It was previously shown that an ensemble
could result in improved model performance [24]. However, the RF ensemble achieved similar performance
measures as the single RF model for protein stability prediction (Table 3.1). We thus selected the SVM
model for further analyses.
Selection of relevant sequence features for model construction
Feature selection was conducted to determine the impact of sequence features in the model’s ability
to discriminate the three protein stability states, and to potentially enhance the model performance. The first
feature selection method ranked the importance of the variables (sequence features) using the Gini index
[22,26]. The approach based on Boruta [25] sets the variable selection threshold based on the value of
shadow attributes, which are shuffled copies of all attributes to create randomness, culminated in the
reduction of the feature set from 31 to 12 features. The second method, recursive feature elimination,
identified a set of 7 features. Interestingly, the two feature selection methods identified several common
features, including the hydrophobicity indices of Fasman and Chothia, some of the Kidera factors, and the
aliphatic index. The first method also identified additional features associated with the putative overall
effect of amino acid substitutions on the peptide, such as the isoelectric point.
However, the SVM models constructed with the selected features did not show improved
performance in the tenfold cross-validation (Table 3.2). The SVM model using all the 31 sequence features
(SVM_Full) achieved higher accuracy, ROC-AUC and MCC than the two models after feature selection
(SVM_12 and SVM_7). One possibility was that the model SVM_Full might be slightly overfitted. To
examine this possibility, we further compared the model performance using an independent test dataset.
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Model performance evaluation using an independent test dataset
When compared using an independent test dataset (s238), the SVM models constructed with the
selected features appeared to give slightly better performance measures than the model with the full feature
set (Table 3.3). In particular, the SVM model using the 12 selected features (SVM_12) achieved slightly
better ROC-AUC and MCC than the other two models (SVM_Full and SVM_7). The results suggest that
the 12-feature set might be optimal for predicting three-state protein stability changes. Using the full set of
31 sequence features could cause model overfitting, whereas the 7-feature set might not provide sufficient
information for prediction.

3.4 Conclusions
In this study, we have developed a new model for three-state prediction of protein stability changes
caused by amino acid substitutions. The SVM model was built with sequence-based features. Feature
selection identified 12 features for accurate protein stability prediction. We further validated the predictive
performance of the model using an independent test dataset. Our results suggest that sequence features can
provide sufficient information for predicting the effect of amino acid substitutions on protein stability.
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Tables

Table 3.1 Performance of the SVM and RF models based on tenfold cross-validation. The models were
constructed using 31 sequence features.

Model

AUC

MCC

Accuracy

SVM

0.8972

0.7038

0.8659

0.8411

0.8907

RF

0.7654

0.5360

0.7938

0.6907

0.8453

RF-E

0.7666

0.5163

0.7826

0.6814

0.8348
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Sensitivity Specificity

Table 3.2 Performance of the SVM models after feature selection based on tenfold cross-validation.
SVM_Full was constructed using all the 31 sequence features; SVM_12 was constructed with 12
selected features; and SVM_7 was constructed with 7 selected features.

Model

AUC

MCC

Accuracy

Sensitivity

Specificity

SVM_Full

0.8972

0.7038

0.8659

0.8411

0.8907

SVM_12

0.8827

0.6115

0.8204

0.7830

0.8578

SVM_7

0.8439

0.5529

0.7902

0.7445

0.8360
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Table 3.3 Predictive performance of the SVM models on an independent test dataset. SVM_Full was
constructed using all the 31 sequence features; SVM_12 was constructed with 12 selected features; and
SVM_7 used 7 selected features.

Model

AUC

MCC

Accuracy

SVM_Full

0.7423

0.3682

0.6647

0.5731

0.7563

SVM_12

0.7477

0.4555

0.7052

0.6120

0.7984

SVM_7

0.7367

0.4452

0.7092

0.6235

0.7950
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Sensitivity Specificity
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Abstract

Background: The importance of mutations in disease phenotype has been studied, with information
available in databases such as OMIM. However, it remains a research challenge for the possibility
of clustering amino acid residues based on an underlying interaction, such as co-evolution, to
understand how mutations in these related sites can lead to different disease phenotypes.
Results: This paper presents an integrative approach to identify groups of co-evolving residues,
known as protein sectors. By studying a protein family using multiple sequence alignments and
statistical coupling analysis, we attempted to determine if it is possible that these groups of residues
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could be related to disease phenotypes. After the protein sectors were identified, disease-associated
residues within these groups of amino acids were mapped to a structure representing the protein
family. In this study, we used the proposed pipeline to analyze two test cases of spermine synthase
and Rab GDP dissociation inhibitor.
Conclusions: The results suggest that there is a possible link between certain groups of co-evolving
residues and different disease phenotypes. The pipeline described in this work could also be used
to study other protein families associated with human diseases.
Keywords: Co-evolving residues, statistical coupling analysis, protein sectors, disease phenotype.

4.1 Background
The role of mutations in disease phenotypes is an important focus for human genetics [13]. The identification of mutations and their link to a disease has generated numerous data entries
which should optimally be accessible for ongoing research efforts. This has resulted in the
establishment of databases such as the Online Mendelian Inheritance in Man (OMIM) [4], where
it is possible to access data regarding a gene or gene product and browse through the information
of how different mutations are associated with reported phenotypes. Even though this represents a
valuable resource for clinical and molecular studies, the challenge of determining if differences in
the phenotypes (severity, expansion of symptoms) within a syndrome can be associated with
changes in specific groups of residues remains to be fully resolved. However, recent approaches in
the study of proteins and their evolution have opened a door to analyze proteins from a different
view [5-9] and attempt to associate reported clinical phenotypes to groups of correlated residues.
The techniques such as statistical coupling analysis (SCA) and direct coupling analysis
(DCA) amongst others [5-7, 10] have approached the study of proteins by focusing on the idea of
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residue co-evolution within the protein super-family [6, 8, 11]. These residues, whose interaction
is not hindered by their spatial distribution, are organized within groups that have a seemingly
underlying evolutionary relationship amongst them. Such groups of residues have been termed
protein sectors and have been identified in protein super-families that comprise various lineages [6,
10]. These protein sectors have been characterized as important to the protein by either contributing
to its biological identity or its function [5, 9].
The statistical coupling analysis requires the use of a large number of sequences as well as
structural models for a representative member of the protein family to be analyzed [6, 7]. Although
some protein structures are still not available, the advancement in crystallography accessibility as
well as sequencing technologies coupled with increasing computational power and protein
modeling accuracy and efficiency, has made it possible to obtain large sets of data in order to
explore these approaches in multiple protein families, including those of clinical significance in
humans [12-14].
Previous studies have focused on identifying co-evolving residues, and therefore
understanding how these correlated amino acid units, and the mutations within these regions, could
affect the protein. The most common approaches consist of biochemical assays that provide
experimental support to the link between correlated residue units and measureable characteristics
such as stability or catalytic activity [6, 11]. However, it is important to note that most of these
studies have focused primarily on the analysis of regions with an associated function, such as
domains, thus concentrating only on a segment of the totality of residues that comprise the proteins.
Although the study of specific regions provides valuable information to further understand
how changes in amino acids can affect the overall function of the protein, the exclusion of residues
outside the defined region could however lead to a possible loss of valuable information regarding
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residue distribution in functional sectors. This is of special importance in human genetic disorders,
where diseases have multiple phenotypes ranging in severity, which can be associated with the
location of a mutation within the protein.
We propose an integrative approach that consists of analyzing full-length sequence
alignments from proteins and the subsequent identification of protein sectors using statistical
coupling analysis [6]. The identified sectors and known mutation data from OMIM as well as other
information resources were then used to determine a possible link between the location of an amino
acid residue change and disease phenotype. Our results based on test case proteins known to be
associated with X-linked intellectual disabilities revealed that it might be possible to associate
disease variants to protein sectors.
4.2 Methods
As shown in Figure 4.1, the pipeline used in our work consisted of three different stages:
(1) dataset acquisition, multiple sequence alignment and curation; (2) identification of protein
sectors and mapping of disease-causing mutations; and (3) association between protein sectors and
disease phenotypes.
Dataset acquisition
The first step was to obtain a reference protein sequence. Selection of the sequence and its
organism is determined based on the type of dataset to be analyzed. The retrieval of homologous
sequences belonging to the protein family to be analyzed was done using one iteration of PSIBLAST with a maximum number of target sequences set to 1000. This allowed us to obtain multiple
sequences representing diverse evolutionary lineages. The motivation behind this was to enrich
sequence diversity, thus allowing for the possible identification of groups of conserved co-evolving
residues. Another reason to attempt to identify various sequences was to diminish the possible bias
towards an organism that has overrepresentation of entries in the database. The approach of protein
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sector analysis may not be applied to disease genes with few homologous sequences in the database.
However, this is not supposed to be a common situation with more and more genomes being
sequenced.
BlastClust [15] was subsequently used to reduce sequence redundancy within the dataset.
The parameters used were: similarity threshold of 85% and 100% coverage. This helped diminish
the over-representation of highly similar proteins with different entry numbers. Clustering of
sequences further reduces the number of partial sequences that could cause alignment discordances
due to their limited size. Further manual curation of the sequences was done in order to generate a
high-quality sequence dataset for the alignment. In our pipeline, we implemented conditions to
maintain dataset quality which primarily consisted of elimination of low quality predicted proteins
and discarding of partial sequences.

Protein structure retrieval
Protein structure files for the reference sequences used in the test cases were obtained from
the Protein Data Bank [16]. The entry numbers were obtained by running a BLAST search with the
reference sequence and setting the PDB as the search database. Highest scoring matches were then
selected and downloaded from the PDB website. The PDB file was used to map the multiple
sequence alignment to the residue positions defined in the structure file. This information was
required for analyzing each site to identify residue co-evolution.
An alternative for proteins without a 3D structure is the use of homology modeling. We
generated such homology structure files for our test sets by using the freely available software such
as CPHmodels 3.2 [17] or the Swiss-Model server [18]. The resulting PDB files could be used in
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the pipeline. This alternative requires the use of a separate numbering file for the residues, which
can be included in the pipeline.

Multiple sequence alignment
Each of the working datasets was subsequently aligned using ClustalW [19] incorporated
in MEGA5 [20]. The parameters were set as default for gap penalties and the substitution matrix
selected was BLOSUM62 [21]. After alignment, manual adjustments were undertaken to further
curate the alignment file. These modifications included the elimination of high gap-creating
sequences and trimming of large sequences (based on comparison of starting and ending residues
of the reference or “seed” sequence). After this was accomplished, gaps were eliminated and
sequences were realigned using the same algorithm and parameters. The final alignment files varied
in the number of sequences, but for each test case there were more than 250 amino acid sequences
in each file.

Protein sector identification
The statistical coupling analysis was undertaken to identify the groups of coevolving
residues. The SCA toolbox for MATLAB was obtained from the Rama Ranganathan laboratory at
the Green Center for Systems Biology, UT Southwestern Medical Center. The MATLAB script
was modified and adapted to analyze the test cases.
The identification of protein sectors was accomplished using the methodology previously
described [6, 11]. This consists of the calculation of the degree of conservation for each amino acid
position. Subsequently, the statistical coupling analysis generates a positional correlation and a
sequence correlation matrix. This was followed by a spectral decomposition and analysis of the
statistically significant eigenvalues, and an independent component analysis, which further defines
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the identified protein sectors. Finally, the protein sectors are mapped onto the primary structure of
the protein based on their position in the structure file. This information can also be used to generate
a 3D structure with different protein sectors (For further information refer to Halabi et al [6]).

Mapping of mutations within protein sectors
The information associated with mutations in a protein family can be obtained from
databases such as OMIM as well as publications related to the protein family, their clinical
importance and reported phenotypes known to be associated with the mutations. The clustering or
grouping of mutations can be based on their location, within one of the major regions: N-terminal,
central/other, and C-terminal. This allows for the preliminary classification of the mutations as well
as the latter characterization of the residues identified within the protein sectors.
The labeling and numbering of residues and their corresponding sectors was done using a
PDB file obtained by BLAST search using the reference sequence for each family as a query. The
full-length sequence was used to maximize the number of possible residues belonging to protein
sectors. By increasing the length and coverage of the alignment, it is possible to identify coevolving residues outside the main protein domain, which could be associated with a disease
phenotype.

Visualization of sectors in the protein 3D structure
The program Jmol (http://jmol.sourceforge.net/) was used to visualize the 3D structures in
PDB files. Protein domains were subsequently identified and colored using the information
available from PDB. Each domain was assigned an arbitrary color, based on visualization purposes
(not functional association). For the visualization of protein sectors, the residues identified were
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assigned the color that corresponded to the group of residues to which they belonged based on the
SCA analysis.
4.3 Results and discussion
Identification of protein sectors
The selection of spermine synthase (SMS) and the Rab GDP dissociation inhibitor 1
(GDI1) as test cases was based on the available information for both proteins. SMS has been widely
studied, with multiple mutations and the associated phenotypes comprehensively described as well
as a vast amount of information on the importance of this molecule in brain development [22-25].
These characteristics as well as the fully resolved crystal structure (PDB: 3C6K) made SMS a good
candidate as a test case.
GDI1 has been associated with non-specific X-linked intellectual disability, with different
mutations being reported [26, 27]. This represents an interesting study case to determine if coevolving residues could possibly be associated with disorders that appear to have clinical and
genetic heterogeneity [26]. This protein also has an available crystal structure (PDB: 1LV0), which
made it a suitable test case to analyze with the proposed approach.
The test cases of SMS and GDI1 were analyzed using full-length sequences and their
corresponding structures. The results reported in this paper were obtained using a personal
computer (Intel Core i7 Q720 at 1.60 GHz, 4.00 GB RAM) installed with the MATLAB 2012a and
SCA packages. The analysis covered 90% of the residues represented in the crystal structures of
SMS [28] and GDI1 [29]. This allowed for further identification of sector-grouped residues, located
across the covered area of the protein. A possible issue is the need of protein structural data for the
analysis. Such data may not be always available. However, this can be addressed using methods
such as homology or ab initio modeling. Since the analysis of residue co-evolution is based on the
multiple sequence alignment, the accuracy of homology modeling does not represent an issue to
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the approach. The structure model is only used to map the positions of the multiple sequence
alignment to the primary structure of the protein. Thus, the modeled structure file can be used in
the pipeline in the same manner as the files obtained from the Protein Data Bank.
The protein sector analysis of both SMS and GDI1 revealed the distribution of groups of
co-evolving residues (Figure 2a and 2b) that present a degree of spatial separation which differs
from that found in protein domains (Figure 3a and 3b). When analyzing the sectors of SMS, we
were able to identify three groups classified as the red, blue and green sector. Our results indicated
that the red and blue sectors appear to be in the N-terminal region and to some extent the long loop
and the beta strand domain (Figure 2a). However, the presence of residues of the red sector appears
to be limited to these three regions, whereas the blue and green sectors span the C-terminal region,
with no red sector residues identified in this region.
For GDI1, our analysis identified three distinct sectors, red, blue and green. The
FAD/NAD(P) binding domain, located in the N-terminal region of GDI1, had amino acid residues
classified within the blue and green sector (Figure 2b), with only three positions (82, 125 and 283)
identified as belonging to the red sector. When analyzing the FAD-linked reductase and the
FAD/NAD(P) binding domain located in the central and C-terminal regions of the protein, the
residues in both are mostly classified as being part of the red sector (Figure 2b), with reduced
presence of residues classified into the green and blue sectors. Although sector distribution of
residues appears to follow a pattern where one group of residues is predominant over the others in
a specific region, our analysis revealed that even within these regions, residues belonging to
different sectors were identified (Figure 2a and 2b). This finding supports a degree of differentiation
between protein sectors and domains.
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Our results indicate that although protein sectors may be distributed across the proteins,
there is a concentration of these co-evolving residues in certain areas of the proteins (Figure 2a and
2b), with stretches of residues that were not identified to be part of any sector. This observation
could be attributed to the presence of conserved catalytic centers or active sites, necessary for
protein function. One example was residue 276 in SMS (Table 1), which is a known active site that
was not assigned to any sector. For GDI1, residue 92 (Table 1) has been reported to be necessary
for the binding and recycling of RAB3 [27], and mutations in this site could lead to a reduction in
its activity. This residue was also not classified in any of the three identified sectors. Because such
important residues tend to be highly conserved, it is possible that these sites are not prone to
undergo the co-evolutionary process
.
Disease-associated residues in protein sectors
The protein sector analysis of our test cases revealed a possible link between different
disease phenotypes and the locations of the mutations within groups of co-evolving residues. We
were able to identify multiple residues, in which disease-causing mutations have been identified
(Table 1). As stated in Halabi et al. [6], groups of co-evolving residues seem to be associated with
specific functions. In SMS, we identified the presence of a sector within the N-terminal region,
which is necessary for protein dimerization. It has been reported that the ability to form dimers is
necessary for full protein functionality. In our analysis, we found that the most severe phenotypes
for the Snyder-Robinson Syndrome were predominantly found in the red sector, with residues
mapped not only to the N-terminal region but also in the long loop and beta-strand domains (Figure
2a and 3a).
The results suggest that protein sectors, when compared to domains, allow for the
clustering of mutations based on the underlying process of residue co-evolution instead of grouping
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them by sequential or spatial locations. The protein sector analysis of SMS has shown that the
known Snyder-Robinson syndrome phenotypes, including expanded phenotypes [30], are mainly
related to the red sector (Table 1), which comprises the N-terminal region as well as the long loop
and beta strand domain. Thus, a protein sector can be associated with diverse functions as
previously reported [6]. It appears that the red sector in SMS comprises regions associated with
both dimerization and protein stability (Table 1), and these spatially distant regions may have
undergone the co-evolutionary process because of their roles in the function of the protein.
Interestingly, another mutation in SMS has been mapped to the green sector. This residue at
position 328 (Table 1) has been associated with a milder form of the Snyder-Robinson syndrome
[31]. It is possible that the green sector in the C-terminal region comprises residues associated with
the enzyme’s substrate recognition [28]. This may lead to a decrease in enzymatic activity, thus
possibly accounting for the milder form of the syndrome [28].
The analysis of GDI1 identified two known mutations located in the green and blue sectors
(Table 1). These amino acid positions (70 and 423) are associated with non-specific X-linked
intellectual disability [26, 27]. The two residues are located in spatially separated regions, with the
residue at position 70 in the N-terminal FAD/NAD(P)-binding domain and the residue at position
423 in the C-terminal region (Figure 2b). It is still unknown whether these two mutations,
distributed in different sectors, may cause any difference in disease phenotypes. Further studies are
needed to explain our findings and expand the knowledge about this protein, including the possible
role of the co-evolving resides in disease. The third residue at position 92 has been proposed as an
important substrate binding site [26, 27], and appears not to be undergoing co-evolution, probably
owing to its significance in stabilizing the Rab-binding region or recognition of the C-terminal
prenyl group in substrate recycling [27]. This may explain why our analysis did not identify it in
any of the three sectors.
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Our results from the protein sector analysis of SMS suggest a possible link between groups
of co-evolving residues and disease severity. However, to fully understand the role of protein
sectors, the use of mutagenic analysis can provide further information. Experimental validation of
our results would present further evidence to support the approach of clustering disease-associated
residues with their corresponding clinical manifestation. In addition, although we have presented a
pipeline useful for clustering mutations, it is possible that other factors, such as the type of amino
acid substitutions, could be the underlying cause of the differences in disease severity.
Nevertheless, by clustering residues into different sectors, our approach can be used as a valuable
aid in further characterizing the possible causes of disease such as intellectual disability. Protein
sector analysis may also provide useful information for understanding the effect of mutations at
spatially distant positions on disease phenotypes.

4.4 Conclusions
We have proposed an integrative approach that makes use of the statistical coupling
analysis method for the study of disease-causing mutations in proteins. Our test cases provided
information regarding the role of protein sectors and how they could be associated to disease
variants. We were also able to identify the effect of mutations in distinct sectors with variations in
the clinical signs of a disease. These findings support the possible role of the protein sectors in
specific functions that when affected could lead to variable phenotypes associated with a complex
syndrome.
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Figures

Figure 4.1 Proposed pipeline for analyzing co-evolving residues from protein families associated
with human diseases. The flow chart includes the alternative of using homology modeling or other
protein modeling methods if the 3D structure is not available. The association of disease
information with protein sectors is in a grey shaded box because it is the end result of the analysis.
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Figure 4.2 Identification of protein sectors in the primary structure of SMS and GDI1. A)
Distribution of the protein sectors within the different regions of human spermine synthase. The
analyzed residues correspond from position 28 to 365 based on the structure (PDB: 3C6K). The
pattern observed appears to correspond to a stratification of sectors where the N-terminal region
associated with dimerization appears to dominate the red sector, whereas the C-terminal region,
ranging from residues 173 to 366, is composed of the blue and green sectors. B) Distribution of
the protein sectors in Rab GDP dissociation inhibitor. The analyzed residues correspond from
positions 1 to 447 based on the PDB structure file (1LV0). The N-terminal FAD/NAD(P) binding
domain appears to be predominantly composed of residues belonging to the green and blue sectors.
The FAD-linked reductase and the C-terminal FAD/NAD(P) binding domains appear to have a
majority of residues classified within the red sector with a small presence of amino acids belonging
to the blue and green sectors.
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Figure 4.3 Representation of protein domains and identified sectors in the 3D structure of spermine
synthase (PDB: 3C6K). A) Protein domains were colored in one of the chains of the homodimer.
Red corresponds to the N-terminal domain, the long loop is in purple, the beta strand domain is in
yellow, and the C-terminal region is in blue, with the catalytic center shown in light blue. B)
Identified protein sectors in spermine synthase. Each sector is represented with a different color,
and appears to have a distribution that is not limited to the described domains.
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Table

Table 4.1 List of the residues associated with diseases in spermine synthase and Rab GDP
dissociation inhibitor.

The disease-associated sites were obtained from OMIM and

publications, and the list is organized according to the residue location in the protein domains.

Residue

Sector

Domain/Region

G56A

Red

N-terminal

Effect/Associated Phenotype
Snyder-Robinson syndrome. Expanded
phenotype of disease reported in [23]
New

G67A

Red

Snyder-Robinson

syndrome

phenotype. Expanded phenotype of

N-terminal

disease reported in [30]
Spermine
Synthase

GDI1

V132A

Red

N-terminal/long loop

I150A

Red

Central (beta-strand)

Y328A

Green

C-terminal/catalytic

L92P

-

FAD/NAD(P)
domain
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binding

Snyder-Robinson syndrome. Expanded
phenotype of disease reported in [24]
Decrease the stability of the C-terminal
region, Snyder-Robinson syndrome

Mild

mental

retardation,

Snyder-

Robinson syndrome

Non-specific mental retardation

R70TER

Green

R423P

Blue

FAD/NAD(P)

binding

domain
FAD/NAD(P)
domain
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binding

Non-specific mental retardation

Non-specific mental retardation
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CHAPTER V – CONCLUSIONS

In this dissertation, we have presented several computational approaches, to analyze both
genes and proteins associated with intellectual disability (ID). We have utilized various datasets,
ranging from multiple sequence alignments to the developmental transcriptome of the brain to
generate new knowledge that can be used in human genetics research.
We developed an expression-based machine learning classifier for prediction of IDassociated long non-coding RNAs (lncRNAs). By using the developing brain transcriptome to
encode a list of ID-causing and non-ID disease genes, we developed a model using Support Vector
Machines. The binary classifier performed well at discriminating between the two classes of genes
and identified possible ID-associated lncRNAs. The use of feature selection did not improved
model performance or provide new insight about ID development. Instead, use of a class-balancing
strategy improved classifier performance. The identified lncRNAs were found to be expressed in
modules co-enriched with known ID genes and associated with neurodevelopmental processes.
These lncRNAs were also found to be expressed in brain tissues. These findings support the roles
of the candidate lncRNAs in ID pathogenesis.
We constructed a three-state protein stability classifier using sequence-based features. By
encoding each sequence in the training set with relevant physico-chemical features, a model was
built using SVM. Through feature selection, we identified informative variables, important to
discriminate between the three states (increase, decrease and no significant change in stability).
Although the model was well-performing based on an independent test set, approaches such as
semi-supervised learning might further improve the protein stability prediction, given the large
number of unlabeled instances currently available.
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We also used statistical coupling analysis (SCA) in the study of ID-causing mutations and
their effect on disease phenotypes. By using the sequences from known ID proteins, we built a
multiple sequence alignment that was used to identify groups of co-evolving residues denominated
protein sectors. Protein sectors are functionally important, and when mutated, protein function can
be affected. Using SCA we identified different mutations in distinct sectors, each associated with
a different phenotypic manifestation for a syndromic ID. The sectors clustered mutations into mild
and severe ID. Our results suggest that SCA can be used to identify functionally important sites
and determine the impact of mutations in the clinical manifestations of disease.
The bioinformatics methods presented in this dissertation can be further improved in the
future. The expression-based classifier used to identify candidate ID-associated lncRNAs can be
improved with the incorporation of target prioritization approach, which would rank the candidate
lncRNAs based on their possible importance to ID pathogenesis. For the protein stability classifier,
the potential use of semi-supervised learning could provide model development with an
improvement in classifier performance by using the numerous unlabeled data instances that are
currently available. Our work on mutations and their effect on disease phenotypes using SCA can
be expanded to study other diseases besides ID. The results from the ID test case suggest SCA can
be used in the study of disease-causing proteins, as well as for studying functionally important sites
in other protein families.
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APPENDIX A – MUTUAL INFORMATION TO IDENTIFY CORRELATED SITES IN
URACIL DNA GLYCOSYLASE SUPERFAMILY

A.1 Introduction

When analyzing a multiple sequence alignment of a protein family to identify co-evolving
residues, it is always reasonable to find three kinds of residues: highly or completely conserved,
partially conserved, and non-conserved. Conserved residues are important because they tend to be
associated with structural interactions. These interactions are usually necessary for structural
integrity, as demonstrated by mutagenesis studies, where substitutions in these amino acid positions
affect the interactions associated with protein folding or stability. However, partially conserved
residues are also of special interest because of the potential information they can provide about the
protein [1,2]. These positions are the result of divergence amongst species. This process leads to
emergence of new sequences or amino acid sites with functional differentiation. Partially conserved
residues appear conserved within a protein sub-family, which gives the residues new functions ,
such as substrate affinity or a specific catalytic action, characteristics that separate each sub-family
from each other [1]. The identification of partially conserved residues is a challenge as their
identification is necessary in evolutionary and functional studies. Currently, the task of identifying
partially conserved residues requires the use of computational and experimental approaches in
order to experimentally corroborate the sites predicted using computational methods [1,2].
Although approaches are available for the identification of partially conserved residues, it
is important to select a method capable of properly identifying the coevolutionary signals that these
residues share. The presence of functional association between amino acid pairs, the potential
structural interactions or the phylogenetic signals in the multiple sequence alignment (MSA) can
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affect the mutual information score [3,4]. This is of special importance because of the proper
determination of partially conserved residues, these must share a coevolutionary signal based on a
functional interaction, and not one defined by their phylogenetic or structural interactions. To
address this, matter information theory, and more specifically mutual information (MI), has been
used to analyze multiple sequence alignments (MSA) of different uracil DNA glycosylase (UDG)
families.
The use of this approach allowed us to analyze the multiple sequence alignment (MSA)
and identify two partially conserved co-evolving residues that appeared to have a significant level
of conservation within each sub-family based on the MSA and the mutual information analysis.
These residues were also analyzed for potential association with a function, an important trait of
partially conserved residues. These amino acid positions, identified as pairs 41E-42G in family 4
and 63Q-64D in family 1, were confirmed to be functionally important through mutational and
biochemical analysis. These results suggest that MI can provide valuable information in the
functional studies of protein families and evolution [5].

A.2 Methods
Mutual information analysis
Residue co-evolution was determined using a mutual information-based tool, MISTIC (Mutual
Information Server to Infer Co-evolution). This approach uses mutual information to determine the
evolutionary relationship between two residue positions in a multiple sequence alignment. Prior to
the MI analysis, dataset acquisition and construction, and multiple sequence alignment were
performed as described in the following steps. The calculation of the MI co-evolution values on the
MISTIC server was carried out as described [3]. This consisted of calculating the frequency of
amino acid pairs by means of weighting and low count correction. The calculated frequency is then
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compared with the expected frequency. MISTIC also assumes that mutations between amino acids
are uncorrelated [3]. Afterwards, the MI scores for the protein family alignment were calculated.
These scores were obtained by calculating a weighted sum of the log ratios of the expected and the
observed frequencies from the amino acid pairs [3]. Mutual information background signal noise
was corrected by implementing the Average Correction Product [3,6]. Subsequently, a z-score
normalization was applied to the MI values. A threshold of 6.5 was used to report co-evolving
residues identified by MI. This value has been reported to have significant values in specificity and
sensitivity [3]. Identification and visualization of co-evolving residues were performed as described
in Supplementary Information.

Dataset acquisition and construction for mutual information analysis
The first step was to obtain the available uracil DNA glycosylase (UDG) sequences. These
were acquired from UniProtKB. A general search was done in order to find significant hits that
could be used to generate a raw dataset, composed of representatives of all the UDG families.
Subsequently, the raw dataset was sorted using a Perl script designed to separate sequences based
on the presence of the distinct UDG family 4 and 1 motifs (GE[A/G][V/P]G and GQDPY,
respectively), as reported in [7]. The output of the script was two distinct files, each containing
approximately 1000 family 4 UDGa and family 1 UNG protein sequences.
The resulting sequences were then subjected to clustering analysis using BlastClust to
reduce redundancy [8,9]. This is of special importance, as it reduces sequence redundancy as well
as the bias effect that overrepresented sequences might have later on the residue co-evolution
analysis [10,11]. The parameters used were: sequence similarity threshold of 75% and coverage
percentage value of 85%. The selection of these parameters reduced the amount of highly similar
sequences with different accession entries from each dataset. This resulted in a significant reduction
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of sequence entries, with each data file containing approximately 200 sequence representatives for
each family.

Multiple sequence alignment
The sequences in the dataset were then aligned using the ClustalW alignment tool
incorporated in MEGA6 [12–14]. Preliminary alignments were performed using the default
parameters followed by manual curation of the alignment. The process eliminated noise from
outlier with no evolutionary, biological and functional relationship to family 4 UDGa and family 1
UNG. By manually examining the alignment, it was possible to eliminate these sequences to obtain
and procure a high quality alignment dataset.
After the first alignment was completed, all gaps were removed from the datasets and a
new alignment was performed, using MEGA6’s implementation of ClustalW. The parameters were
the following: the substitution matrix was BLOSUM62 [15,16], with gap opening penalty of 20
and gap extension penalty of 5. These stringent parameters were selected in order to reduce the
number of gaps within the alignment. The resulting alignment was then subjected to a second round
of manual curation, where any remaining outliers were eliminated. Subsequently, gaps were
removed and sequences were re-aligned. The ClustalW alignment output was then subjected to a
final manual inspection. Afterwards, a refining alignment was done using MUSCLE [17].

Identification and visualization of co-evolving residues
The curated sequence alignment files were uploaded into the MISTIC web server, and a
reference sequence for each family was selected. The selection was based on two criteria: being the
representative of the largest luster and second, having a similarity of more than 25% with the
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family’s canonic structure. This allows for the reference to be a significant representative of each
of the UDG families studied.
After alignment file uploaded and reference sequence selected, the next step was
modification of the default web server parameters. The protein structure file was left blank, as our
analysis was intended to identify co-evolving relationships using only protein sequences. Within
the advanced options the maximum fraction of gaps per column allowed in the calculations was set
from 0.5 (default value) to 0.3. This number was selected in previous co-evolution analysis, and
has yielded good results [11]. Finally, the file was submitted to the web server for analysis.
After the analysis was completed, results were visualized using the tools incorporated
within the MISTIC web server. A sequential circular representation of the multiple sequence
alignment, known as the Circos diagram, maps the amino acid positions to the reference sequence.
In this diagram, there are three major components represented with a color scale. The first is the
square boxes under each amino acid position, these boxes represent the conservation of the residue.
The colors of these boxes range from red (highly conserved) to blue (less conserved). The second
is the histograms associated with each position representing the cumulative mutual information,
which illustrates the correlation a given residue has with other positions. The higher the histogram,
the more residues that position is correlated with. Finally, the edges or lines connecting the coevolving residues describe the relationship between positions in the multiple sequence alignment
based on their mutual information. Red lines represent the top 5%; black lines refer to the MI
relationships between 95% and 70%; and the gray lines denote the remaining MI relationships [3].
The MI analysis was also represented as a network, which was generated by Cytoscape
[18]. Within the network representation, each node was an amino acid positions within the multiple
sequence alignment, mapped to the reference sequence for each family. Residue conservations,

106

similarly to the Circos diagram, were represented by a color scale, where red represented highly
conserved residues and blue less conserved ones. The lines or edges of the network represented
significant MI values (those higher than the 6.5 threshold) [3].

A.4 Results and Discussion
Mutual Information (MI) was used to analyze a multiple sequence alignment from subfamilies 1 and 4 UDGs to identify a doublet of partially coevolving residues. The positions
identified in this doublet were considered specificity-determining sites (SDPs), identified as
residues of importance to protein function [19]. The reason for defining the amino acids in the
doublet as SDPs was their functional activity as part of motif 1 and their high conservation within
the family (Figure A-1). These residues were confirmed as functionally important through
mutational and biochemical analysis. MI also revealed that these residues are partially conserved
sites. These positions presented high conservation in the multiple sequence alignment for residues
41E-42G in family 4 and 63Q-64D in family 1.
The use of MI is based on its ability to identify underlying relationships such as coevolution between pairs of residues [19]. The two residues can be either in close distance
(neighboring) or separated by large blocks of amino acids. In the case of the identified pairs 41E42G in family 4 and 63Q-64D in family 1 (Figure A-1), these doublets are subjected to what
MISTIC identifies as structural and functional linkage as both are coevolving residues that are
neighboring positions [3]. The presence of structural and functional linkage results in the doublets
41E-42G in family 4 and 63Q-64D having a significant cumulative MI value (Figure A-1),
represented as the outward bar in the Circos graphs. A closer inspection of the figure revealed that
these neighboring sites have multiple correlations with other sites. Some of these interactions are
ranked in the top 5% (red-colored lines) based on the MI score. Most of the correlations are within
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the range of 95-70%. It is possible to trace some of these correlations to positions in motif 2. It
appears that, based on Figure A-1, residues on motif 2 could be partially conserved as their amino
acid identities, which change from family to family but appear highly conserved within each family.
The correlation between the doublets 41E-42G in family 4 and 63Q-64D in family 1 and positions
in motif 2 could be the result of potential structural and functional linkage. These could account for
the observed formation of a pocket between motifs 1 and 2 that interacts with its substrate. The
ability of MI to uncover this kind of associations is considered a robust approach to study coevolution [4]. An advantage of MI over other approaches that identify coevolutionary interactions
is the correction for phylogenetic bias in multiple sequence alignments, especially implemented in
MISTIC [3,4]. The doubts 41E-42G in family 4 and 63Q-64D in family 1 were also correlated to
non-conserved sites. Previous studies have proposed that the non-conserved sites could be positions
where balancing mutations have taken place. It has been speculated that neutral sites could have
developed correlations with functionally important sites to mitigate the effects of deleterious
mutations [1,2].

A.5 Conclusions
We have demonstrated that mutual information (MI) can be used to uncover coevolution
between residues in a multiple sequence alignment. In the study of the UDG superfamily, we
focused on two families, 1 and 4, and initially identified two residue positions that had partial
conservation. These were conserved within each sub-family but variable in the super-family. In the
study, it was confirmed with biochemical assays that these sites were functionally important for the
sub-families. These assays validated our results and supported the significance of MI in the
identification and functional study of proteins.
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In this research, we identified correlation in terms of possible coevolution between residues
of different motifs (1 and 2) that have been identified to be of functional importance in the UDG
family. The use of MI also revealed a possible role of non-conserved residues as possible sites
where balancing mutations can occur. These non-specific sites would serve to minimize the effect
of deleterious mutations that would disrupt protein function or structural stability. This could
account for pairwise correlations between functionally important sites and positions with a
seemingly randomly distributed across the protein with neither conservation or function. In a recent
work, MI was also used to

study UDG family 3 (SMUG1) and supported the functional

characterization of the SMUG-1 glycosylase representative isolated from Listeria innocua [20].

Note
The MI analysis of UDG superfamily has been incorporated in two peer-reviewed publications:
Xia, B., Liu, Y., Guevara, J., Li, J., Jilich, C., Yang, Y., Wang, L., Dominy, B.N. and Cao, W.,
2017. Correlated Mutation in the Evolution of Catalysis in Uracil DNA Glycosylase
Superfamily. Scientific Reports, 7.
Li J, Yang Y, Guevara J, Wang L, Cao W. Identification of a prototypical single-stranded uracil
DNA glycosylase from Listeria innocua. DNA Repair (Amst). Elsevier; 2017;57:107–15.
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Figures

Figure A-1 Circos graph of the Mutual Information analysis of families 1 and 4. The graph
represents the positions in the reference sequence for (A) family 1 and (B) family 4 of UDG. The
lines represent the number of significant correlations, with the red lines representing the top 5%.
The outward bars for each position are the cumulative mutual information, based on the MI score
of each position and its neighbor residue. The external layer ranging from red to blue is the residue
conservation, from highly conserved (deep red) to low conservation (blue) Adapted from Xia et al.
2017 [5].
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